<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">FGBDZV8FvjvQd8SFnSNnPCF</article-id>
      <article-id pub-id-type="other">00018</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2010000200018</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(10)09400218</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2010000200018</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Escore de c&#225;lcio coronariano prediz estenose e eventos na insufici&#234;ncia renal cr&#244;nica pr&#233;-transplante</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ros&#225;rio</surname>
            <given-names>Miguel Abra&#227;o</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lima</surname>
            <given-names>Jos&#233; Jayme de</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Parga</surname>
            <given-names>Jos&#233; R.</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>&#193;vila</surname>
            <given-names>Luiz F.</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gowdak</surname>
            <given-names>Luis H.</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lemos</surname>
            <given-names>Pedro A.</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rochitte</surname>
            <given-names>Carlos E.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
        <institution content-type="orgdiv1">Faculdade de Medicina </institution>
        <institution content-type="orgdiv2">Hospital das Cl&#237;nicas</institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>02</month>
        <year>2010</year>
      </pub-date>
      <volume>94</volume>
      <issue>2</issue>
      <fpage>252</fpage>
      <lpage>260</lpage>
      <history>
        <date date-type="received">
          <day>10</day>
          <month>06</month>
          <year>2008</year>
        </date>
        <date date-type="rev-recd">
          <day>19</day>
          <month>02</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>03</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: A doen&#231;a arterial coronariana (DAC) &#233; a principal causa de &#243;bito em pacientes com insufici&#234;ncia renal cr&#244;nica (IRC). Os exames n&#227;o invasivos tradicionais para detec&#231;&#227;o de DAC e predi&#231;&#227;o de eventos t&#234;m apresentado resultados insuficientes nesse grupo. A avalia&#231;&#227;o do escore de c&#225;lcio coronariano (ECC) por tomografia computadorizada tem comprovado valor progn&#243;stico na popula&#231;&#227;o sem doen&#231;a renal. OBJETIVO: Avaliar a acur&#225;cia do ECC para detectar DAC obstrutiva e prever eventos cardiovasculares em candidatos a transplante renal comparada &#224; angiografia coronariana invasiva (ACI) quantitativa. M&#201;TODOS: Foram avaliados 97 pacientes com IRC e idade &gt; 35anos. Foi considerada DAC obstrutiva a presen&#231;a de estenose &gt;50% ou &gt;70% pela ACI. Dados descritivos, concord&#226;ncia, testes diagn&#243;sticos, Kaplan-Meier e an&#225;lise multivariada foram utilizados. RESULTADOS: O escore de Agatston m&#233;dio foi de 580,6 &#177; 1.102,2; os valores m&#237;nimos e m&#225;ximos foram 0 e 7.994, e mediana de 176. Apenas 14 pacientes tinham escore de c&#225;lcio de zero. N&#227;o houve diferen&#231;as entre as etnias e a maior presen&#231;a de c&#225;lcio regional associou-se a maior probabilidade de estenose coron&#225;ria no mesmo segmento. O escore de c&#225;lcio de Agatston apresentou boa acur&#225;cia para o diagn&#243;stico de estenose, &gt;50% e &gt;70% com &#225;rea sob a curva ROC de 0,75 e 0,70, respectivamente. No limiar de 400, o escore de c&#225;lcio identificou o subgrupo com maior taxa de eventos cardiovasculares em tempo m&#233;dio de seguimento de 29,1&#177;11,0 meses. CONCLUS&#195;O: O ECC na avalia&#231;&#227;o de DAC apresentou boa performance diagn&#243;stica e progn&#243;stica para eventos cardiovasculares em pacientes com insufici&#234;ncia renal cr&#244;nica (IRC).</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Tomografia computadorizada de emiss&#227;o</kwd>
        <kwd>escore de c&#225;lcio</kwd>
        <kwd>doen&#231;a da art&#233;ria coronariana</kwd>
        <kwd>insufici&#234;ncia renal cr&#244;nica</kwd>
        <kwd>determina&#231;&#227;o</kwd>
        <kwd>progn&#243;stico</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>05</day>
        <month>05</month>
        <year>2010</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>ARTIGO ORIGINAL </p>
    <p> TOMOGRAFIA/RESSON&#194;NCIA</p>
    <p>
      <bold>Escore de c&#225;lcio coronariano prediz estenose e eventos na insufici&#234;ncia renal cr&#244;nica pr&#233;-transplante</bold>
    </p>
    <p>Miguel Abra&#227;o Ros&#225;rio<xref ref-type="fn" rid="back1"><sup><bold>*</bold></sup></xref>; Jos&#233; Jayme de Lima; Jos&#233; R. Parga; Luiz F. &#193;vila; Luis H. Gowdak; Pedro A. Lemos; Carlos E. Rochitte<xref ref-type="fn" rid="back1"><sup><bold>*</bold></sup></xref></p>
    <p>Instituto do Cora&#231;&#227;o (InCor) do Hospital das Cl&#237;nicas da Faculdade de Medicina da Universidade de S&#227;o Paulo, S&#227;o Paulo,SP - Brasil</p>
    <p>
      <xref ref-type="corresp" rid="back">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO: </bold> A doen&#231;a arterial coronariana (DAC) &#233; a principal causa de &#243;bito em pacientes com insufici&#234;ncia renal cr&#244;nica (IRC). Os exames n&#227;o invasivos tradicionais para detec&#231;&#227;o de DAC e predi&#231;&#227;o de eventos t&#234;m apresentado resultados insuficientes nesse grupo. A avalia&#231;&#227;o do escore de c&#225;lcio coronariano (ECC) por tomografia computadorizada tem comprovado valor progn&#243;stico na popula&#231;&#227;o sem doen&#231;a renal. </p>
    <p><bold>OBJETIVO:</bold> Avaliar a acur&#225;cia do ECC para detectar DAC obstrutiva e prever eventos cardiovasculares em candidatos a transplante renal comparada &#224; angiografia coronariana invasiva (ACI) quantitativa. </p>
    <p><bold>M&#201;TODOS:</bold> Foram avaliados 97 pacientes com IRC e idade <underline>&gt;</underline> 35anos. Foi considerada DAC obstrutiva a presen&#231;a de estenose <underline>&gt;</underline>50% ou <underline>&gt;</underline>70% pela ACI. Dados descritivos, concord&#226;ncia, testes diagn&#243;sticos, Kaplan-Meier e an&#225;lise multivariada foram utilizados. </p>
    <p><bold>RESULTADOS:</bold> O escore de Agatston m&#233;dio foi de 580,6 &#177; 1.102,2; os valores m&#237;nimos e m&#225;ximos foram 0 e 7.994, e mediana de 176. Apenas 14 pacientes tinham escore de c&#225;lcio de zero. N&#227;o houve diferen&#231;as entre as etnias e a maior presen&#231;a de c&#225;lcio regional associou-se a maior probabilidade de estenose coron&#225;ria no mesmo segmento. O escore de c&#225;lcio de Agatston apresentou boa acur&#225;cia para o diagn&#243;stico de estenose, <underline>&gt;</underline>50% e <underline>&gt;</underline>70% com &#225;rea sob a curva ROC de 0,75 e 0,70, respectivamente. No limiar de 400, o escore de c&#225;lcio identificou o subgrupo com maior taxa de eventos cardiovasculares em tempo m&#233;dio de seguimento de 29,1&#177;11,0 meses. </p>
    <p><bold>CONCLUS&#195;O:</bold> O ECC na avalia&#231;&#227;o de DAC apresentou boa performance diagn&#243;stica e progn&#243;stica para eventos cardiovasculares em pacientes com insufici&#234;ncia renal cr&#244;nica (IRC).</p>
    <p><bold>Palavras-chave: </bold> Tomografia computadorizada de emiss&#227;o, escore de c&#225;lcio, doen&#231;a da art&#233;ria coronariana, insufici&#234;ncia renal cr&#244;nica, determina&#231;&#227;o, progn&#243;stico.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>A doen&#231;a arterial coronariana (DAC) &#233; a principal causa de &#243;bito em pacientes com insufici&#234;ncia renal cr&#244;nica (IRC)<sup>1</sup>. O risco de morte por DAC nesse grupo de pacientes &#233; maior que na popula&#231;&#227;o geral. Dependendo do est&#225;gio da IRC<sup>2</sup>, o risco cardiovascular pode aumentar significativamente. Nos pacientes em di&#225;lise, no est&#225;gio 5 da IRC, o risco cardiovascular &#233; de 20 a 1.000 vezes maior que em pessoas da popula&#231;&#227;o geral sem doen&#231;a renal, dependendo da idade da popula&#231;&#227;o estudada<sup>2</sup>. Entre pacientes em hemodi&#225;lise ou di&#225;lise peritoneal, a preval&#234;ncia de doen&#231;a coronariana &#233; de cerca de 40%<sup>1</sup>. Nos Estados Unidos, cerca de 10% dos pacientes em di&#225;lise morrem de doen&#231;a card&#237;aca a cada ano, sendo um consenso que pacientes com IRC devem ser considerados de alto risco para o desenvolvimento de eventos cardiovasculares, devendo submeter-se &#224; avalia&#231;&#227;o cardiovascular frequente<sup>3</sup>. Ainda nesse grupo, o diabete melito imp&#245;e risco de mortalidade semelhante ao da DAC<sup>4</sup>.</p>
    <p>Testes n&#227;o invasivos, empregados na avalia&#231;&#227;o de DAC em pacientes com IRC, t&#234;m como objetivos identificar a presen&#231;a de DAC e avaliar o risco de eventos cardiovasculares e &#243;bito<sup>5</sup>.</p>
    <p>Em pacientes com IRC e alto risco para DAC, a preval&#234;ncia de DAC e a incid&#234;ncia de eventos adversos cardiovasculares maiores (EACM) s&#227;o altos. Portanto, para melhorar o progn&#243;stico &#233; necess&#225;ria a procura constante por DAC, atrav&#233;s dos melhores m&#233;todos diagn&#243;sticos dispon&#237;veis. O servi&#231;o especializado em IRC do InCor recentemente identificou que DAC significante e complica&#231;&#245;es cardiovasculares n&#227;o est&#227;o relacionados com a maioria dos fatores de risco cl&#225;ssicos neste grupo espec&#237;fico de pacientes com IRC. Os autores concluem que pacientes com diabete, doen&#231;a arterial perif&#233;rica e infarto pr&#233;vio est&#227;o sob alto risco de DAC, EACM ou ambos, e, portanto, devem ser encaminhados para procedimento diagn&#243;stico invasivo<sup>6</sup>. Com rela&#231;&#227;o a estrat&#233;gias de avalia&#231;&#227;o da DAC nesses pacientes e sua rela&#231;&#227;o com o progn&#243;stico, De Lima e cols.<sup>7</sup> publicaram dados conclusivos indicando que o estudo para avalia&#231;&#227;o da DAC com maior poder progn&#243;stico foi a angiografia coronariana invasiva (ACI), quando comparada a testes n&#227;o invasivos (medicina nuclear e ecocardiografia de estresse)<sup>7</sup>. Isso abriu a possibilidade para a investiga&#231;&#227;o dos novos m&#233;todos de diagn&#243;stico n&#227;o invasivos, que ainda n&#227;o haviam sido avaliados nesse grupo de pacientes com IRC e vinham demonstrando boa performance em pacientes com DAC na popula&#231;&#227;o geral. Entre esses novos m&#233;todos est&#227;o: resson&#226;ncia magn&#233;tica cardiovascular e a tomografia computadorizada de m&#250;ltiplas colunas de detectores (TCMD), com avalia&#231;&#227;o da calcifica&#231;&#227;o coronariana (escore de c&#225;lcio coronariano - ECC) e detec&#231;&#227;o da estenose coronariana (angiografia coron&#225;ria por tomografia).</p>
    <p>Um dos mais importantes motivos para avaliar a presen&#231;a de DAC &#233; o uso dessa informa&#231;&#227;o como dado progn&#243;stico, podendo assim ter uma estimativa dos riscos individuais de eventos cardiovasculares e ajustar as medidas terap&#234;uticas e preventivas de forma adequada ao risco de determinado paciente. Enquanto a ACI demonstrou ser um exame progn&#243;stico poderoso<sup>7</sup>, as novas t&#233;cnicas de TCMD n&#227;o foram ainda testadas extensamente em pacientes com IRC pr&#233;-transplante.</p>
    <p>Assim, nossa hip&#243;tese foi de que o uso da TCMD possa ser &#250;til no diagn&#243;stico de DAC significativa e na estima&#231;&#227;o progn&#243;stica nos pacientes com IRC candidatos a transplante renal. Nosso objetivo foi investigar se a calcifica&#231;&#227;o coron&#225;ria detectada pela TCMD &#233; capaz de predizer a presen&#231;a de estenose coron&#225;ria e eventos cardiovasculares em pacientes com IRC.</p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>Foram inclu&#237;dos 97 pacientes com IRC em programa de hemodi&#225;lise, indicados para serem submetidos a transplante renal, e com indica&#231;&#227;o cl&#237;nica de ACI. A indica&#231;&#227;o cl&#237;nica de ACI foi baseada no fato de os pacientes pertencerem ao grupo de alto risco para DAC ou por meio de sintomas e/ou exames n&#227;o invasivos pr&#233;vios que levassem a suspeita de DAC. Os pacientes considerados como de alto risco foram aqueles com ao menos um dos seguintes crit&#233;rios:</p>
    <p>1) idade <underline>&gt;</underline>50 anos;</p>
    <p>2) diabete melito;</p>
    <p>3) hist&#243;ria ou evid&#234;ncia cl&#237;nica de doen&#231;a cardiovascular<sup>8</sup>. O recrutamento foi realizado pelo ambulat&#243;rio especializado em IRC do Servi&#231;o de Hipertens&#227;o do Instituto do Cora&#231;&#227;o da Faculdade de Medicina da Universidade de S&#227;o Paulo. Nesse servi&#231;o, o manejo dos pacientes de alto risco ou com suspeita de DAC inclui a ACI devido &#224; sua melhor performance progn&#243;stica<sup>7</sup>. A TCMD com contraste iodado n&#227;o i&#244;nico foi realizada ap&#243;s exclus&#227;o de contraindica&#231;&#227;o ao estudo e consentimento livre e esclarecido assinado. Este projeto foi aprovado pela comiss&#227;o de &#233;tica e pesquisa do InCor e HCFMUSP (CAPEPesq, n&#250;mero 0195/04) e obteve suporte financeiro da Funda&#231;&#227;o de Amparo &#224; Pesquisa do Estado de S&#227;o Paulo (FAPESP, processo n&#250;mero 2004-08363-6). Os crit&#233;rios de inclus&#227;o foram: homens ou mulheres; com 35 anos de idade ou mais; com IRC; em programa de di&#225;lise e candidatos a transplante renal; com indica&#231;&#227;o cl&#237;nica de ACI e com intervalo m&#225;ximo com a TCMD de um ano (realizada no m&#225;ximo at&#233; um ano antes da inclus&#227;o ou com ACI planejada para os pr&#243;ximos meses). Os crit&#233;rios de exclus&#227;o foram: alergia conhecida a meio de contraste iodado; fibrila&#231;&#227;o atrial, taquiarritmia ou bloqueio atrioventricular avan&#231;ado; evid&#234;ncia de insufici&#234;ncia card&#237;aca sintom&#225;tica grave (NYHA classe III/IV); estenose a&#243;rtica conhecida; cirurgia card&#237;aca pr&#233;via; stent coron&#225;rio; intoler&#226;ncia ou contraindica&#231;&#227;o a beta-bloqueadores conhecida, como doen&#231;a pulmonar broncoesp&#225;stica.</p>
    <p>Neste estudo, foi considerada DAC significativa a presen&#231;a de pelo menos uma estenose <underline>&gt;</underline>50% por paciente, em ramo coron&#225;rio principal e di&#226;metro luminal maior que 1,5mm, identificada pela ACI. Foram tamb&#233;m analisadas secundariamente as estenoses <underline>&gt;</underline>70%, assim como a an&#225;lise segmentar nesses dois limiares.</p>
    <p>Dos 97 pacientes dispon&#237;veis para o estudo, 63 (65,0%) eram do sexo masculino e 34 (35,0%) do sexo feminino, com idade m&#233;dia &#177; desvio padr&#227;o de 56,7&#177;7,4 (<xref ref-type="table" rid="t01">tabela 1</xref>). A idade m&#237;nima foi de 35 anos e a m&#225;xima de 76 anos.</p>
    <p content-type="asset">
      <table-wrap id="t01">
        <graphic xlink:href="1678-4170-abc-94-02-0252-00018-gt01.jpg"/></table-wrap>
    </p>
    <p>A preval&#234;ncia dos fatores de risco tradicionais para DAC foi a seguinte: hipertens&#227;o arterial sist&#234;mica - 87 (89,6%); diabete melito - 37 (38,1%); dislipidemia - 33 (34,0%); arteriopatia 33 (34,0%); angina - 28 (28,9%); tabagismo atual - 20 (20,6%); antecedentes familiares de DAC - 18 (18,6%); acidente vascular cerebral (AVC) - 12 (12,4%); insufici&#234;ncia card&#237;aca congestiva (ICC) - 8 (8,2%); infarto agudo do mioc&#225;rdio (IAM) - 7 (7,2%). Cabe ressaltar que os pacientes que tiveram alguns sintomas ou angina eram todos est&#225;veis e os sintomas foram posteriores a indica&#231;&#227;o de coronariografia invasiva. N&#227;o foram inclu&#237;dos pacientes com indica&#231;&#227;o de coronariografia para investiga&#231;&#227;o de dor tor&#225;cica de in&#237;cio recente (e potencialmente inst&#225;veis). Assim, todos os pacientes inclu&#237;dos no protocolo eram assintom&#225;ticos no momento da inclus&#227;o.</p>
    <p>Os dados antropom&#233;tricos da nossa amostra e a frequ&#234;ncia card&#237;aca durante a aquisi&#231;&#227;o do exame de tomografia est&#227;o detalhados na <xref ref-type="table" rid="t01">tabela 1</xref>. A m&#233;dia do tempo de di&#225;lise foi de 40,2&#177;42,1 meses, com mediana de 26,5 meses, m&#237;nimo de 2 meses e m&#225;ximo de 240 meses.</p>
    <p>
      <bold>Protocolo de aquisi&#231;&#227;o das imagens pela TCMD</bold>
    </p>
    <p>Os exames de TCMD foram realizados em aparelhos de 16 e 64 colunas de detectores (<italic>Aquilion16</italic>&#153; e <italic>Aquilion64</italic>&#153; <italic>- Toshiba</italic>&#153; <italic>Medical Systems Corporation</italic>, Otawara, Jap&#227;o) no Instituto do Cora&#231;&#227;o (InCor - HCFMUSP).</p>
    <p>Os pacientes foram orientados quanto aos detalhes do exame e posicionados na mesa da TCMD em posi&#231;&#227;o de dec&#250;bito dorsal, deslocados para direita, mantendo o cora&#231;&#227;o no centro do foco de raios-X. Todos os pacientes receberam monitoriza&#231;&#227;o eletrocardiogr&#225;fica para sincroniza&#231;&#227;o com a aquisi&#231;&#227;o da imagem e seguimento da frequ&#234;ncia card&#237;aca durante o exame. Os bra&#231;os do paciente foram posicionados acima da cabe&#231;a e com os cabos do ECG passando por fora do campo de escaneamento.</p>
    <p>A frequ&#234;ncia card&#237;aca (FC) dos pacientes durante a realiza&#231;&#227;o do exame foi de 61,1 &#177; 6,9 bpm. Os pacientes com frequ&#234;ncia card&#237;aca acima de 70bpm na chegada &#224; tomografia receberam beta-bloqueador endovenoso, metoprolol, na dose necess&#225;ria para atingir a FC alvo de 60 bpm ou at&#233; a dose m&#225;xima de 15 mg, pois estes participaram de um protocolo com aquisi&#231;&#227;o de angiotomografia de coron&#225;rias associado. As frequ&#234;ncias card&#237;acas foram sempre medidas durante pausa respirat&#243;ria.</p>
    <p>
      <bold>Protocolo da TCMD - aquisi&#231;&#227;o das imagens</bold>
    </p>
    <p>Inicialmente, obt&#237;nhamos a chamada imagem localizat&#243;ria. Uma janela de varredura era, ent&#227;o, visualmente estabelecida com base nessa primeira imagem, com cobertura desde a bifurca&#231;&#227;o da traqueia (carina) at&#233; a completa inclus&#227;o da silhueta card&#237;aca. Esse planejamento foi usado para a aquisi&#231;&#227;o do escore de c&#225;lcio.</p>
    <p>O escore de c&#225;lcio foi ent&#227;o obtido atrav&#233;s de aquisi&#231;&#227;o prospectiva e sincronizada ao tra&#231;ado de ECG. As imagens foram adquiridas com espessura de corte de 3,0 mm e campo de vis&#227;o de 200 a 220 mm, para obten&#231;&#227;o de imagens axiais do t&#243;rax cobrindo toda a &#225;rea card&#237;aca, permitindo a visualiza&#231;&#227;o das art&#233;rias coron&#225;rias e da eventual calcifica&#231;&#227;o em topografia das mesmas. As imagens foram adquiridas em momento diast&#243;lico definido de acordo com a frequ&#234;ncia card&#237;aca do paciente. A aquisi&#231;&#227;o do escore de c&#225;lcio necessitou de pausa inspirat&#243;ria m&#233;dia de cerca de 15 s, de acordo com o protocolo j&#225; validado<sup>9</sup>. Os par&#226;metros de aquisi&#231;&#227;o do escore de c&#225;lcio foram: velocidade de rota&#231;&#227;o do tubo de 0.75 s, colima&#231;&#227;o dos detectores 4 por 3.0 mm, voltagem do tubo de 120 kV, e corrente do tubo de 300 mA.</p>
    <p>
      <bold>Aquisi&#231;&#227;o da angiografia coron&#225;ria invasiva</bold>
    </p>
    <p>As angiografias coron&#225;rias foram realizadas de acordo com as t&#233;cnicas j&#225; consagradas e padronizadas na rotina do servi&#231;o de hemodin&#226;mica do Instituto do Cora&#231;&#227;o (InCor) HC-FMUSP<sup>10</sup> e com indica&#231;&#227;o cl&#237;nica independente do protocolo de pesquisa.</p>
    <p>
      <bold>Seguimento dos eventos cardiovasculares</bold>
    </p>
    <p>Os dados de seguimento foram obtidos de pelo menos uma das tr&#234;s fontes:</p>
    <p>1) consulta de rotina no ambulat&#243;rio especializado,</p>
    <p>2) telefonema para o paciente ou parente questionando sobre o estado de sa&#250;de do paciente ou</p>
    <p>3) revis&#227;o do prontu&#225;rio do paciente.</p>
    <p>No nosso protocolo, foram considerados como eventos cardiovasculares: morte card&#237;aca (definida por dois cardiologistas em consenso ap&#243;s revis&#227;o dos dados dispon&#237;veis); infarto agudo do mioc&#225;rdio (eleva&#231;&#227;o enzim&#225;tica 3x o valor normal, associada a quadro agudo de dor tor&#225;cica e/ou altera&#231;&#227;o do ECG compat&#237;vel com isquemia mioc&#225;rdica); acidente vascular cerebral (diagn&#243;stico cl&#237;nico ou por m&#233;todo de imagem); doen&#231;a vascular perif&#233;rica grave ou gangrena (isquemia de membros grave que levou a procedimento cir&#250;rgico associado); angina inst&#225;vel (dor tor&#225;cica t&#237;pica, altera&#231;&#227;o de ECG compat&#237;vel com isquemia mioc&#225;rdica em pacientes com probabilidade no m&#237;nimo intermedi&#225;ria de DAC); insufici&#234;ncia card&#237;aca congestiva (diagn&#243;stico cl&#237;nico e ecocardiograma indicando redu&#231;&#227;o da fra&#231;&#227;o de eje&#231;&#227;o do VE); e edema agudo de pulm&#227;o (diagn&#243;stico cl&#237;nico e radiografia do t&#243;rax evidenciando edema pulmonar intersticial).</p>
    <p>
      <bold>An&#225;lise de dados</bold>
    </p>
    <p>
      <bold>An&#225;lise do escore de c&#225;lcio</bold>
    </p>
    <p>Escores de c&#225;lcio total, segundo o m&#233;todo descrito por Agatston e cols.<sup>9</sup>, foram obtidos para cada paciente (<xref ref-type="fig" rid="f1">figura 1</xref>) em <italic>workstation Vitrea</italic>&#153;2, vers&#227;o 3,5 <italic>- Vital Images Inc,</italic> Plymouth, MN, EUA. Na an&#225;lise das imagens de escore de c&#225;lcio, utilizamos duas medidas: a do escore de Agatston<sup>9</sup> e a do volume de c&#225;lcio. O escore de Agatston tem sido o mais utilizado na literatura e mant&#233;m rela&#231;&#227;o com doen&#231;a coron&#225;ria e mesmo com DAC obstrutiva quando em n&#237;veis muito elevados (percentil acima de 75% ou 90%).</p>
    <fig id="f1">
      <graphic xlink:href="1678-4170-abc-94-02-0252-00018-gf01.jpg"/></fig>
    <p>
      <bold>Angiografia coron&#225;ria quantitativa ou QCA</bold>
    </p>
    <p>Um observador experiente na t&#233;cnica de QCA e que n&#227;o participou da an&#225;lise da TCMD, tamb&#233;m de forma cega e independente, analisou todas as ACI aplicando a t&#233;cnica da <italic>QCA (Coronary Analysis Angiographic System - CASS II</italic>, <italic>Pie Medical Imaging BV</italic> &#153;, <italic>Maastricht, The Netherlands</italic>)<sup>11-14</sup>.</p>
    <p>Assim sendo, o di&#226;metro de cada estenose visualmente tida como pelo menos intermedi&#225;ria (<underline>&gt;</underline> 50%) foi objetivamente designado em valores porcentuais relativos ao chamado "di&#226;metro de refer&#234;ncia" (di&#226;metro do segmento do mesmo vaso que se encontrava livre de doen&#231;a e se localizava em posi&#231;&#227;o imediatamente proximal &#224; les&#227;o), sendo determinado em duas dire&#231;&#245;es ortogonais, com a m&#233;dia entre eles estabelecendo a gravidade final da estenose.</p>
    <p>Todas as les&#245;es com di&#226;metro de refer&#234;ncia <underline>&gt;</underline> 1,5 mm foram inclu&#237;das na an&#225;lise comparativa deste estudo. Caso o mesmo segmento da art&#233;ria principal ou ramo de primeira ordem possu&#237;ssem mais de uma estenose significativa, apenas a estenose mais grave era comparada &#224; sua correspondente pela TCMD<sup>10,15,16</sup>.</p>
    <p>
      <bold>An&#225;lise estat&#237;stica</bold>
    </p>
    <p>As vari&#225;veis descritivas foram expressas como m&#233;dias e um desvio-padr&#227;o e medianas, se apropriado. Por ter apresentado uma curva de distribui&#231;&#227;o assim&#233;trica, os n&#237;veis de calcifica&#231;&#227;o arterial coronariana foram expressos por suas medianas, percentis e valores extremos.</p>
    <p>A fim de estabelecermos as medidas de acur&#225;cia diagn&#243;stica da TCMD, lan&#231;amos m&#227;o de uma cl&#225;ssica tabela 2x2.</p>
    <p>O teste exato de Fisher foi utilizado para calcular as medidas de acur&#225;cia diagn&#243;stica da TCMD, comparada &#224; QCA, no que diz respeito &#224; identifica&#231;&#227;o de estenoses coronarianas com di&#226;metros <underline>&gt;</underline> 50% e <underline>&gt;</underline> 70%. Para compara&#231;&#227;o dos diferentes escores de c&#225;lcio coronariano obtidos pela TCMD nos respectivos territ&#243;rios, utilizamos o teste de Mann-Whitney.</p>
    <p>Ainda foram utilizadas curvas de Kaplan-Meier para a an&#225;lise de taxa de eventos no tempo em diversos subgrupos. Todas as an&#225;lises realizadas no programa estat&#237;stico Stata&#153;/SE 8 (<italic>StataCorp LP, College Station, TX</italic>).</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>A nossa amostra de pacientes com IRC apresentou escore de Agatston m&#233;dio de 580,6 &#177; 1.102,2. Os valores m&#237;nimos e m&#225;ximos foram 0 e 7.994. Dos 97 pacientes com escore de c&#225;lcio analisados, apenas 14 pacientes n&#227;o tinham nenhuma calcifica&#231;&#227;o coronariana detect&#225;vel, isto &#233;, escore de c&#225;lcio de zero. S&#227;o apresentados tamb&#233;m na <xref ref-type="table" rid="t02">tabela 2</xref> os valores de escore e volume total para toda a &#225;rvore coron&#225;ria e para cada territ&#243;rio coronariano espec&#237;fico, com suas m&#233;dias, desvios padr&#245;es, mediana, valores m&#237;nimos e m&#225;ximos em cada categoria. Os valores dos percentis para idade e sexo encontram-se na <xref ref-type="table" rid="t3">tabela 3</xref>. Os valores m&#233;dios dos percentis para idade, sexo e etnia, baseado no estudo <italic>MESA</italic> (<italic>Multiethnic Study of Atherosclerosis</italic>) s&#227;o referidos como MESA, na <xref ref-type="table" rid="t3">tabela 3</xref>.</p>
    <p content-type="asset">
      <table-wrap id="t02">
        <graphic xlink:href="1678-4170-abc-94-02-0252-00018-gt02.jpg"/></table-wrap>
    </p>
    <table-wrap id="t3">
      <graphic xlink:href="1678-4170-abc-94-02-0252-00018-gt03.jpg"/></table-wrap>
    <p>A distribui&#231;&#227;o do ECC &#233; significativamente assim&#233;trica, sendo assim, relatamos a mediana do escore total de Agatston e a sua distribui&#231;&#227;o por percentis (<xref ref-type="table" rid="t3">tabela 3</xref>).</p>
    <p>Com rela&#231;&#227;o &#224; etnia dos pacientes, n&#227;o houve diferen&#231;a significativa dos ECCs m&#233;dios entre os grupos &#233;tnicos: brancos (698,5&#177;1.309, mediana 205, n=64); negros (389,0&#177;761,80, mediana 158, n=10); orientais (728,1&#177;1045, mediana 272,5, n=8); pardos ou mesti&#231;os (217,3&#177;350,0, mediana 37, n=22); com p = 0,36 pelo teste n&#227;o param&#233;trico de Kruskal-Wallis.</p>
    <p>
      <bold>Escore de c&#225;lcio <italic>versus</italic> estenose coronariana</bold>
    </p>
    <p>Comparamos o grau de calcifica&#231;&#227;o entre os pacientes com ou sem coronariopatia obstrutiva significativa (estenose <underline>&gt;</underline>70%). Pelo cateterismo demonstrou-se que o escore de Agatston &#233; significativamente maior no grupo com DAC significativa no cateterismo, pelo teste de Wilcoxon (<xref ref-type="table" rid="t02">tabela 2</xref>). O tempo decorrido entre a realiza&#231;&#227;o da TCMD e da ACI foi em m&#233;dia de 99,03 dias com desvio padr&#227;o de 87,65 dias e mediana de 79 dias. O intervalo m&#237;nimo foi de 2 dias e o m&#225;ximo de 380 dias, sendo apenas 2 casos acima de um ano e 16 casos com intervalo superior a seis meses.</p>
    <p>Avaliamos o percentual de pacientes com estenose coron&#225;ria <underline>&gt;</underline> 50% e <underline>&gt;</underline> 70% pela ACI nos diversos extratos de ECC. Observamos um crescimento progressivo, linear e significativo entre o percentual de pacientes com DAC e o grau de calcifica&#231;&#227;o coron&#225;ria (<xref ref-type="fig" rid="f2">figura 2</xref>). Os pacientes com estenose pela ACI <underline>&gt;</underline>50% foram 55/97 (57%) e os pacientes com estenose <underline>&gt;</underline>70% foram 25/97(26%).</p>
    <fig id="f2">
      <graphic xlink:href="1678-4170-abc-94-02-0252-00018-gf02.jpg"/></fig>
    <p>Na an&#225;lise da calcifica&#231;&#227;o coronariana <italic>versus</italic> a ACI, observamos que para estenoses <underline>&gt;</underline> 50% e <underline>&gt;</underline> 70%, o limiar de 400 de escore de Agatston se associou estatisticamente a maior propor&#231;&#227;o de pacientes com estenoses significantes (p &lt; 0,001, pelo qui-quadrado, <xref ref-type="fig" rid="f2">figura 2</xref>).</p>
    <p>A an&#225;lise regional do escore de c&#225;lcio tamb&#233;m revelou as mesmas diferen&#231;as observadas para o escore global, exceto no TCE. Assim, os escores regionais foram significativamente maiores em segmentos com estenoses <underline>&gt;</underline> 50% e 70% quando comparados com aqueles segmentos sem estenoses.</p>
    <p>A acur&#225;cia do escore de c&#225;lcio para diagnosticar a estenose coron&#225;ria tamb&#233;m foi avaliada pelo uso do percentil do estudo <italic>MESA</italic> no limiar do percentil 75, e &#233; demonstrada na <xref ref-type="table" rid="t04">tabela 4</xref>.</p>
    <p content-type="asset">
      <table-wrap id="t04">
        <graphic xlink:href="1678-4170-abc-94-02-0252-00018-gt04.jpg"/></table-wrap>
    </p>
    <p>Dos 14 pacientes com escore e c&#225;lcio zero: quatro (28%) apresentaram estenose <underline>&gt;</underline>50% na ACI e apenas dois (14%) estenose <underline>&gt;</underline> 70%. Utilizando o escore de c&#225;lcio de forma bin&#225;ria, igual a zero ou maior que zero, para predizer a estenose coronariana, obtivemos na nossa amostra um valor preditivo negativo de 71% para estenose <underline>&gt;</underline>50% e 86% para estenose <underline>&gt;</underline>70%.</p>
    <p>
      <bold>Escore de c&#225;lcio - capacidade preditiva da estenose coronariana</bold>
    </p>
    <p>Investigamos, usando regress&#227;o log&#237;stica e construindo curvas ROC (<italic>receiver-operating characteristics</italic>), se o escore de c&#225;lcio consegue prever a presen&#231;a de estenose coronariana na ACI.</p>
    <p>Avaliamos a acur&#225;cia do escore de c&#225;lcio pela an&#225;lise da curva ROC tanto para o limiar de estenose de 50% (&#225;rea sob a curva de 0,75) como de 70% (&#225;rea sob a curva de 0,70), definidos pela ACI (<xref ref-type="fig" rid="f03">figura 3</xref>, painel A para o limiar de 50% e B para o limiar de 70%).</p>
    <p content-type="asset">
      <fig id="f03">
        <graphic xlink:href="1678-4170-abc-94-02-0252-00018-gf03.jpg"/></fig>
    </p>
    <p>Baseado na regress&#227;o log&#237;stica e nas curvas ROC acima, podemos afirmar que o escore de c&#225;lcio consegue prever a presen&#231;a de uma estenose coronariana <underline>&gt;</underline>50% pela ACI, no melhor limiar de 186,53, com acur&#225;cia de 66%, sensibilidade 65%, especificidade 66%, valor preditivo positivo 72%, e valor preditivo negativo 60% (p=0,01).</p>
    <p>Da mesma forma, o escore de c&#225;lcio consegue prever a presen&#231;a de uma estenose coronariana <underline>&gt;</underline>70% pela ACI, no melhor limiar de 1.330,72, com acur&#225;cia de 65%, sensibilidade 64%, especificidade 65%, valor preditivo positivo 39%, e valor preditivo negativo 84% (p=0,01).</p>
    <p>Os limiares acima tamb&#233;m foram aqueles que apresentaram os melhores valores preditivos negativos poss&#237;veis, podendo assim responder a quest&#227;o de qual n&#237;vel de escore de c&#225;lcio pode prever aus&#234;ncia de estenose significativa.</p>
    <p>
      <bold>Escore de c&#225;lcio <italic>versus</italic> eventos cardiovasculares</bold>
    </p>
    <p>O tempo m&#233;dio de seguimento para avalia&#231;&#227;o de eventos na nossa popula&#231;&#227;o foi de 29,1&#177;11,0 meses, com mediana de 31 meses e seguimento m&#237;nimo de 3 meses e m&#225;ximo de 43 meses. Os eventos observados e suas frequ&#234;ncias absolutas foram: infarto agudo do mioc&#225;rdio (oito), acidente vascular cerebral (cinco), doen&#231;a vascular perif&#233;rica grave ou grangrena (quatro), angina inst&#225;vel (duas), morte s&#250;bita (duas), insufici&#234;ncia card&#237;aca congestiva (uma) e edema agudo de pulm&#227;o (um). O total de eventos foi de 23. Dos 97 pacientes, 23 casos apresentaram eventos, perfazendo 23,7% da nossa amostra. N&#227;o apresentaram eventos 71 pacientes e houve perda de seguimento em tr&#234;s casos.</p>
    <p>Com rela&#231;&#227;o &#224; predi&#231;&#227;o de eventos que o ECC pudesse ter nesta popula&#231;&#227;o, observamos que o percentil do estudo MESA dessa popula&#231;&#227;o n&#227;o foi preditivo significativamente de eventos, tanto no limiar de 75% como no limiar de 90%.</p>
    <p>Ainda na an&#225;lise de eventos, testamos o escore de c&#225;lcio como preditor de eventos em v&#225;rios limiares de corte: 0 (presen&#231;a ou aus&#234;ncia), 10, 100 e 400. O limiar de escore de c&#225;lcio de 400 mostrou curvas de Kaplan-Meier com taxa de eventos significativamente diferentes, mostrada na <xref ref-type="fig" rid="f4">figura 4</xref>.</p>
    <fig id="f4">
      <graphic xlink:href="1678-4170-abc-94-02-0252-00018-gf04.jpg"/></fig>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>Este foi o primeiro trabalho a demonstrar que a TCMD fornece informa&#231;&#245;es progn&#243;sticas nos pacientes com IRC, candidatos a transplante renal.</p>
    <p>O ECC apresentou correla&#231;&#227;o com a presen&#231;a de estenose e boa performance diagn&#243;stica com rela&#231;&#227;o &#224; ACI para detec&#231;&#227;o de estenose, e mostrou poder progn&#243;stico para o n&#237;vel de corte de 400 de escore Agatston na nossa popula&#231;&#227;o.</p>
    <p>Observaram-se escores m&#233;dios bastante elevados. Escores acima de 300 ou 400 s&#227;o relatados na literatura em pacientes sem IRC como sendo associados &#224; alta probabilidade de DAC obstrutiva e ao alto risco de eventos cardiovasculares<sup>17,18</sup>. Nos pacientes com IRC dial&#237;tica, &#233; relatada uma magnitude 2,5 vezes maior de calcifica&#231;&#227;o coronariana<sup>19-22</sup>, muito embora essa calcifica&#231;&#227;o aumentada tenha sido relacionada mais aos fatores de risco tradicionais para DAC aumentados nessa popula&#231;&#227;o, do que a fatores relacionados &#224; fun&#231;&#227;o renal ou &#224; di&#225;lise<sup>23</sup>. &#201; descrita uma calcifica&#231;&#227;o vascular relacionada &#224; di&#225;lise, chamada arteriopatia ur&#234;mica, caracterizada por calcifica&#231;&#227;o difusa da camada m&#233;dia de art&#233;rias de pequeno a m&#233;dio di&#226;metro e arter&#237;olas, com prolifera&#231;&#227;o intimal e trombose, que pode causar &#250;lceras e necrose de pele. O quanto esse mecanismo pode influenciar na calcifica&#231;&#227;o das art&#233;rias coron&#225;rias nesse grupo de pacientes n&#227;o est&#225; completamente esclarecido<sup>24</sup>.</p>
    <p>Embora tenha sido observada em pacientes da popula&#231;&#227;o geral uma correla&#231;&#227;o apenas parcial entre a calcifica&#231;&#227;o e a obstru&#231;&#227;o coron&#225;ria<sup>18</sup>, houve uma correla&#231;&#227;o e acur&#225;cia diagn&#243;sticas boas entre o escore de c&#225;lcio e a estenose coron&#225;ria pela TCMD e pela ACI no grupo de pacientes com IRC. O percentil de 75% do estudo MESA mostrou sensibilidade de 82% e 84% para detec&#231;&#227;o de DAC com les&#227;o obstrutiva <underline>&gt;</underline> 50% e 70%, respectivamente. Esse resultado nos parece extremamente encorajador do uso dessa t&#233;cnica simples, com baixa radia&#231;&#227;o e sem uso de contraste. Esses n&#237;veis de sensibilidade n&#227;o s&#227;o habitualmente atingidos, nem mesmo por exames com estresse farmacol&#243;gico, como a cintilografia e o ecocardiograma. Em um estudo do nosso grupo, utilizando a resson&#226;ncia magn&#233;tica cardiovascular com estresse com dipiridamol e a cintilografia, obtivemos sensibilidade de 84% e 66%, respectivamente, nesse grupo de pacientes<sup>25</sup>. N&#227;o obstante, tanto a resson&#226;ncia como os outros m&#233;todos de estresse s&#227;o exames mais complexos, demorados, dispendiosos, e com maior risco para o paciente que o escore de c&#225;lcio.</p>
    <p>A utiliza&#231;&#227;o do escore de c&#225;lcio absoluto rendeu valores de sensibilidade menores do que aquele atingido pelo percentil 75%. Assim, conclu&#237;mos que o uso do percentil 75% do estudo MESA foi mais acurado para a detec&#231;&#227;o de DAC que o escore de c&#225;lcio em n&#250;mero absoluto. A melhor acur&#225;cia do escore de c&#225;lcio absoluto para detec&#231;&#227;o de estenose <underline>&gt;</underline>50% na ACI foi de 186. Esses valores limiares apresentaram o melhor valor preditivo negativo poss&#237;vel nessa amostra, e dessa forma, nossos dados indicam que um escore de c&#225;lcio &lt;186 ou abaixo do percentil 75% pode afastar a suspeita de estenose coronariana significativa com probabilidade pr&#243;xima a 90% nesse grupo de pacientes.</p>
    <p>Assim, a utilidade do escore de c&#225;lcio parece ser ainda mais significativa no grupo de pacientes com IRC. Essa correla&#231;&#227;o se mostrou verdadeira tanto para o escore de Agatston global como regional. Podemos ainda lembrar que, em pacientes com alto grau de calcifica&#231;&#227;o, a angiotomografia de coron&#225;rias pode ser limitada na avalia&#231;&#227;o da redu&#231;&#227;o luminal, muito embora t&#233;cnicas especiais e observadores experientes possam tornar essa avalia&#231;&#227;o &#250;til clinicamente<sup>26</sup>.</p>
    <p>Os dados da literatura t&#234;m indicado o escore de c&#225;lcio muito mais como preditor de eventos cardiovasculares do que da estenose coron&#225;ria em pacientes da popula&#231;&#227;o geral<sup>17</sup>. O estudo MESA recentemente confirmou esse dado nas v&#225;rias etnias<sup>27</sup>, refor&#231;ando o papel progn&#243;stico do escore de c&#225;lcio. No nosso estudo, a correla&#231;&#227;o do c&#225;lcio com eventos nos pacientes com IRC mostrou-se significativa para o n&#237;vel de 400 de escore de Agatston, sugerindo que este possa ser usado como um limiar de predi&#231;&#227;o progn&#243;stica. Assim, nossos dados sugerem que, no grupo de pacientes com IRC, o escore de c&#225;lcio tem valor preditivo n&#227;o s&#243; para eventos como tamb&#233;m para a detec&#231;&#227;o de estenose coron&#225;ria, diferentemente da popula&#231;&#227;o geral. Nesse aspecto, uma limita&#231;&#227;o deste estudo foi a presen&#231;a de sete pacientes com infarto mioc&#225;rdico pr&#233;vio, o que pode ter elevado o poder diagn&#243;stico do teste nessa popula&#231;&#227;o. Por&#233;m, em an&#225;lise de sensibilidade, excluindo-se esses pacientes, n&#227;o houve altera&#231;&#227;o significativa na performance diagn&#243;stica do escore de c&#225;lcio no nosso grupo.</p>
    <p>Por outro lado, nosso estudo utilizou uma metodologia avan&#231;ada, recentemente descrita para a segmenta&#231;&#227;o da &#225;rvore coronariana e an&#225;lise estat&#237;stica<sup>28</sup>, que representa uma evolu&#231;&#227;o no m&#233;todo cient&#237;fico nesse campo e foi utilizada por n&#243;s em estudo multic&#234;ntrico de grande impacto<sup>29</sup>.</p>
    <p>Algumas importantes implica&#231;&#245;es de uso cl&#237;nico podem ser derivadas dos nossos resultados em associa&#231;&#227;o com os dados da literatura e do nosso grupo.</p>
    <p>Tendo em vista o alto &#237;ndice de ACI na qual o resultado &#233; aus&#234;ncia de DAC ou DAC n&#227;o obstrutiva (aproximadamente 40%)<sup>30</sup>, associado &#224;s caracter&#237;sticas de excelente perfil de seguran&#231;a do escore de c&#225;lcio, seu baixo custo e a boa sensibilidade demonstrada pelos nossos resultados nos pacientes com IRC, sugere-se que este possa ser um instrumento com uma boa rela&#231;&#227;o custo-efetividade na detec&#231;&#227;o de DAC. A avalia&#231;&#227;o da rela&#231;&#227;o custo-efetividade n&#227;o foi objetivo deste trabalho, sendo que esse dado precisa ser investigado por trabalhos futuros, diretamente voltados para essa an&#225;lise.</p>
    <p>
      <bold>Conclus&#227;o</bold>
    </p>
    <p>Podemos afirmar que o escore de c&#225;lcio pela tomografia computadorizada apresentou boa capacidade diagn&#243;stica para predizer estenose coronariana (percentil 75 ou 186 no valor absoluto), e progn&#243;stica na predi&#231;&#227;o de eventos cardiovasculares (no valor absoluto de 400) em pacientes com insufici&#234;ncia renal.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo foi financiado pela FAPESP e Funda&#231;&#227;o Zerbini.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte de tese de doutorado de Miguel Abra&#227;o Ros&#225;rio pelo Instituto do Cora&#231;&#227;o (Incor) do Hospital das Cl&#237;nicas da Faculdade de Medicina da Universidade de S&#227;o Paulo. </p>
    <p>
      <fn id="back" fn-type="corresp">
        <p><a href="#top" link-type="internal"/> Correspond&#234;ncia: </p>
        <p> Carlos E. Rochitte </p>
        <p> Instituto do Cora&#231;&#227;o - InCor </p>
        <p> Setor de Resson&#226;ncia Magn&#233;tica Cardiovascular </p>
        <p> Av. Dr. En&#233;as de Carvalho Aguiar, 44 - Andar AB - Cerqueira C&#233;sar </p>
        <p> 05403-000 - S&#227;o Paulo, SP - Brasil </p>
        <p> E-mail: </p>
        <p>
          <email xlink:href="rochitte@incor.usp.br">rochitte@incor.usp.br</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 10/06/08; revisado recebido em 19/02/09; aceito em 27/03/09. </p>
    <p>
      <fn id="back1">
        <label>*</label>
        <p> Ambos os autores contribu&#237;ram igualmente para este manuscrito</p>
      </fn>
    </p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Levey AS, Beto    JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, et al. Controlling the epidemic    of cardiovascular disease in chronic renal disease: what do we know? What do    we need to learn? Where do we go from here? National Kidney Foundation Task    Force on Cardiovascular Disease. Am J Kidney Dis. 1998; 32: 853-906.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease</article-title>
          <source>Am J Kidney Dis</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>853</fpage>
          <lpage>906</lpage>
          <volume>32</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Levey</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Beto</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Coronado</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Eknoyan</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Foley</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Kasiske</surname>
              <given-names>BL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Schiffrin EL,    Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system.    Circulation. 2007; 116: 85-97.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Chronic kidney disease: effects on the cardiovascular system</article-title>
          <source>Circulation</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>85</fpage>
          <lpage>97</lpage>
          <volume>116</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Schiffrin</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Lipman</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Mann</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Foley RN, Parfrey    PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal    disease. Am J Kidney Dis. 1998; 32: S112-S119.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Clinical epidemiology of cardiovascular disease in chronic renal disease</article-title>
          <source>Am J Kidney Dis</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>S112</fpage>
          <lpage>S119</lpage>
          <volume>32</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Foley</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Parfrey</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Sarnak</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Gowdak LH, de    Paula FJ, Cesar LA, Filho EE, Ianhez LE, Krieger EM, et al. Diabetes and coronary    artery disease impose similar cardiovascular morbidity and mortality on renal    transplant candidates. Nephrol Dial Transplant. 2007; 22 (5): 1456-61.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Diabetes and coronary artery disease impose similar cardiovascular morbidity and mortality on renal transplant candidates</article-title>
          <source>Nephrol Dial Transplant</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>1456</fpage>
          <lpage>61</lpage>
          <issue>5</issue>
          <volume>22</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Gowdak</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>de Paula</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Cesar</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Filho</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Ianhez</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Krieger</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Vaitkus PT.    Current status of prevention, diagnosis, and management of coronary artery disease    in patients with kidney failure. Am Heart J. 2000; 139: 1000-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Current status of prevention, diagnosis, and management of coronary artery disease in patients with kidney failure</article-title>
          <source>Am Heart J</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>1000</fpage>
          <lpage>8</lpage>
          <volume>139</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Vaitkus</surname>
              <given-names>PT</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Gowdak LH, de    Paula FJ, Cesar LA, Martinez Filho EE, Ianhez LE, Krieger EM, et al. Screening    for significant coronary artery disease in high-risk renal transplant candidates.    Coron Artery Dis. 2007; 18: 553-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Screening for significant coronary artery disease in high-risk renal transplant candidates</article-title>
          <source>Coron Artery Dis</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>553</fpage>
          <lpage>8</lpage>
          <volume>18</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Gowdak</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>de Paula</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Cesar</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Martinez Filho</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Ianhez</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Krieger</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. De Lima JJ,    Sabbaga E, Vieira ML, de Paula FJ, Ianhez LE, Krieger EM, et al. Coronary angiography    is the best predictor of events in renal transplant candidates compared with    noninvasive testing. Hypertension. 2003; 42: 263-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing</article-title>
          <source>Hypertension</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>263</fpage>
          <lpage>8</lpage>
          <volume>42</volume>
          <person-group person-group-type="author">
            <name>
              <surname>De Lima</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Sabbaga</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Vieira</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>de Paula</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Ianhez</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Krieger</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Le A, Wilson    R, Douek K, Pulliam L, Tolzman D, Norman D, et al. Prospective risk stratification    in renal transplant candidates for cardiac death. Am J Kidney Dis. 1994; 24:    65-71.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prospective risk stratification in renal transplant candidates for cardiac death</article-title>
          <source>Am J Kidney Dis</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>65</fpage>
          <lpage>71</lpage>
          <volume>24</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Le</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Douek</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Pulliam</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Tolzman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Norman</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Agatston AS,    Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification    of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol.    1990;15: 827-32.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Quantification of coronary artery calcium using ultrafast computed tomography</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>1990</year>
          </date>
          <fpage>827</fpage>
          <lpage>32</lpage>
          <volume>15</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Agatston</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Janowitz</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Hildner</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Zusmer</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Viamonte M</surname>
              <given-names>Jr</given-names>
            </name>
            <name>
              <surname>Detrano</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Bashore TM,    Bates ER, Berger PB, Clark DA, Cusma JT, Dehmer GJ, et al. American College    of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert    Consensus Document on cardiac catheterization laboratory standards. A report    of the American College of Cardiology Task Force on Clinical Expert Consensus    Documents. J Am Coll Cardiol. 2001; 37: 2170-214.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards: A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>2170</fpage>
          <lpage>214</lpage>
          <volume>37</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bashore</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Bates</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Berger</surname>
              <given-names>PB</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Cusma</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Dehmer</surname>
              <given-names>GJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Dietz U, Rupprecht    HJ, Brennecke R, Fritsch HP, Woltmann J, Blankenberg S, et al. Comparison of    QCA systems. Int J Card Imaging. 1997; 13 (4): 271-80.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Comparison of QCA systems</article-title>
          <source>Int J Card Imaging</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>271</fpage>
          <lpage>80</lpage>
          <issue>4</issue>
          <volume>13</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Dietz</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Rupprecht</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Brennecke</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Fritsch</surname>
              <given-names>HP</given-names>
            </name>
            <name>
              <surname>Woltmann</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Blankenberg</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Foley DP, Escaned    J, Strauss BH, di Mario C, Haase J, Keane D, et al. Quantitative coronary angiography    (QCA) in interventional cardiology: clinical application of QCA measurements.    Prog Cardiovasc Dis. 1994; 36: 363-84.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Quantitative coronary angiography (QCA) in interventional cardiology: clinical application of QCA measurements</article-title>
          <source>Prog Cardiovasc Dis</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>363</fpage>
          <lpage>84</lpage>
          <volume>36</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Foley</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Escaned</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Strauss</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>di Mario</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Haase</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Keane</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Keane D, Haase    J, Slager CJ, Montauban VS, Lehmann KG, Ozaki Y, et al. Comparative validation    of quantitative coronary angiography systems: results and implications from    a multicenter study using a standardized approach. Circulation. 1995; 91: 2174-83.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Comparative validation of quantitative coronary angiography systems: results and implications from a multicenter study using a standardized approach</article-title>
          <source>Circulation</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>2174</fpage>
          <lpage>83</lpage>
          <volume>91</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Keane</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Haase</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Slager</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Montauban</surname>
              <given-names>VS</given-names>
            </name>
            <name>
              <surname>Lehmann</surname>
              <given-names>KG</given-names>
            </name>
            <name>
              <surname>Ozaki</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Takazawa K,    Fujita M, Tanaka N, Takeda K, Ishimaru M, Kowaguchi H, et al. Comparison of    lumen area after PTCA by IVUS and QCA. Heart Vessels. 1997; (Suppl 12): 217-20.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Comparison of lumen area after PTCA by IVUS and QCA</article-title>
          <source>Heart Vessels</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>217</fpage>
          <lpage>20</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Takazawa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fujita</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Takeda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ishimaru</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kowaguchi</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Cormack AM.    Nobel award address: early two-dimensional reconstruction and recent topics    stemming from it. Med Phys. 1980; 7: 277-82.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Nobel award address: early two-dimensional reconstruction and recent topics stemming from it</article-title>
          <source>Med Phys</source>
          <date>
            <year>1980</year>
          </date>
          <fpage>277</fpage>
          <lpage>82</lpage>
          <volume>7</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cormack</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Hounsfield    GN. Nobel lecture, 8 December 1979. Computed medical imaging. J Radiol. 1980;    61: 459-68.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Nobel lecture, 8 December 1979: Computed medical imaging</article-title>
          <source>J Radiol</source>
          <date>
            <year>1980</year>
          </date>
          <fpage>459</fpage>
          <lpage>68</lpage>
          <volume>61</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hounsfield</surname>
              <given-names>GN</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Greenland P,    LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined    with Framingham score for risk prediction in asymptomatic individuals. JAMA.    2004; 291: 210-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals</article-title>
          <source>JAMA</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>210</fpage>
          <lpage>5</lpage>
          <volume>291</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Greenland</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>LaBree</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Azen</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Doherty</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Detrano</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Thompson GR,    Partridge J. Coronary calcification score: the coronary-risk impact factor.    Lancet. 2004; 363: 557-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Coronary calcification score: the coronary-risk impact factor</article-title>
          <source>Lancet</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>557</fpage>
          <lpage>9</lpage>
          <volume>363</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Thompson</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Partridge</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Braun J, Oldendorf    M, Moshage W, Heidler R, Zeitler E, Luft FC. Electron beam computed tomography    in the evaluation of cardiac calcification in chronic dialysis patients. Am    J Kidney Dis. 1996; 27: 394-401.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients</article-title>
          <source>Am J Kidney Dis</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>394</fpage>
          <lpage>401</lpage>
          <volume>27</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Braun</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Oldendorf</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Moshage</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Heidler</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Zeitler</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Luft</surname>
              <given-names>FC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Goodman WG,    Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, et al. Coronary-artery calcification    in young adults with end-stage renal disease who are undergoing dialysis. N    Engl J Med. 2000; 342: 1478-83.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>1478</fpage>
          <lpage>83</lpage>
          <volume>342</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Goodman</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Goldin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kuizon</surname>
              <given-names>BD</given-names>
            </name>
            <name>
              <surname>Yoon</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gales</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sider</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Haydar AA,    Hujairi NM, Covic AA, Pereira D, Rubens M, Goldsmith DJ. Coronary artery calcification    is related to coronary atherosclerosis in chronic renal disease patients: a    study comparing EBCT-generated coronary artery calcium scores and coronary angiography.    Nephrol Dial Transplant. 2004; 19: 2307-12.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: a study comparing EBCT-generated coronary artery calcium scores and coronary angiography</article-title>
          <source>Nephrol Dial Transplant</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>2307</fpage>
          <lpage>12</lpage>
          <volume>19</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Haydar</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Hujairi</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Covic</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rubens</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Goldsmith</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Raggi P, Boulay    A, Chasan-Taber S, Amin N, Dillon M, Burke SK, et al. Cardiac calcification    in adult hemodialysis patients: a link between end-stage renal disease and cardiovascular    disease? J Am Coll Cardiol. 2002; 39: 695-701.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac calcification in adult hemodialysis patients: a link between end-stage renal disease and cardiovascular disease?</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>695</fpage>
          <lpage>701</lpage>
          <volume>39</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Raggi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Boulay</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chasan-Taber</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Amin</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Dillon</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Burke</surname>
              <given-names>SK</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Dellegrottaglie    S, Saran R, Gillespie B, Zhang X, Chung S, Finkelstein F, et al. Prevalence    and predictors of cardiovascular calcium in chronic kidney disease (from the    Prospective Longitudinal RRI-CKD Study). Am J Cardiol. 2006; 98: 571-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prevalence and predictors of cardiovascular calcium in chronic kidney disease (from the Prospective Longitudinal RRI-CKD Study)</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>571</fpage>
          <lpage>6</lpage>
          <volume>98</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Dellegrottaglie</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Saran</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gillespie</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Finkelstein</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Budisavljevic    MN, Cheek D, Ploth DW. Calciphylaxis in chronic renal failure. J Am Soc Nephrol.    1996; 7: 978-82.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Calciphylaxis in chronic renal failure</article-title>
          <source>J Am Soc Nephrol</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>978</fpage>
          <lpage>82</lpage>
          <volume>7</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Budisavljevic</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Cheek</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ploth</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Andrade JM.    Estudo de perfus&#227;o e viabilidade mioc&#225;rdicas por resson&#226;ncia    magn&#233;tica em pacientes com doen&#231;a renal cr&#244;nica candidatos    a transplante renal. [Tese]. S&#227;o Paulo: Faculdade de Medicina    da Universidade de S&#227;o Paulo; 2006.</mixed-citation>
        <element-citation publication-type="thesis">
          <source>Estudo de perfus&#227;o e viabilidade mioc&#225;rdicas por resson&#226;ncia magn&#233;tica em pacientes com doen&#231;a renal cr&#244;nica candidatos a transplante renal</source>
          <date>
            <year>2006</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Andrade</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. Cordeiro MA,    Lardo AC, Brito MS, Rosario Neto MA, Siqueira MH, Parga JR, et al. CT angiography    in highly calcified arteries: 2D manual vs. modified automated 3D approach to    identify coronary stenoses. Int J Cardiovasc Imaging. 2006; 22: 507-16.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>CT angiography in highly calcified arteries: 2D manual vs. modified automated 3D approach to identify coronary stenoses</article-title>
          <source>Int J Cardiovasc Imaging</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>507</fpage>
          <lpage>16</lpage>
          <volume>22</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cordeiro</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Lardo</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Brito</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Rosario Neto</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Siqueira</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Parga</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <mixed-citation>27. Detrano R,    Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, et al. Coronary calcium as    a predictor of coronary events in four racial or ethnic groups. N Engl J Med.    2008; 358: 1336-45.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Coronary calcium as a predictor of coronary events in four racial or ethnic groups</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>1336</fpage>
          <lpage>45</lpage>
          <volume>358</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Detrano</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Guerci</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Carr</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Bild</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Burke</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Folsom</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B28">
        <mixed-citation>28. Miller JM,    Dewey M, Vavere AL, Rochitte CE, Niinuma H, Arbab-Zadeh A, et al. Coronary CT    angiography using 64 detector rows: methods and design of the multi-centre trial    CORE-64. Eur Radiol. 2009; 19 (4): 816-28.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Coronary CT angiography using 64 detector rows: methods and design of the multi-centre trial CORE-64</article-title>
          <source>Eur Radiol</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>816</fpage>
          <lpage>28</lpage>
          <issue>4</issue>
          <volume>19</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Miller</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Dewey</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vavere</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Rochitte</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Niinuma</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Arbab-Zadeh</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B29">
        <mixed-citation>29. Miller JM,    Rochitte CE, Dewey M, Arbab-Zadeh A, Niinuma H, Gottlieb I, et al. Diagnostic    performance of coronary angiography by 64-row CT. N Engl J Med. 2008; 359: 2324-36.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Diagnostic performance of coronary angiography by 64-row CT</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>2324</fpage>
          <lpage>36</lpage>
          <volume>359</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Miller</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Rochitte</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Dewey</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Arbab-Zadeh</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Niinuma</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Gottlieb</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories/>
      <title-group>
        <article-title xml:lang="es">Score de calcio coronario predice estenosis y eventos en la insuficiencia renal cr&#243;nica pre trasplante</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>FUNDAMENTO: La enfermedad arterial coronaria (EAC) es la principal causa de &#243;bito en pacientes con insuficiencia renal cr&#243;nica (IRC). Los ex&#225;menes no invasivos tradicionales para detecci&#243;n de EAC y predicci&#243;n de eventos vienen presentando resultados insuficientes en este grupo. La evaluaci&#243;n del score de calcio coronario (SCC) por tomograf&#237;a computarizada ha estado comprobando valor pron&#243;stico en la poblaci&#243;n sin enfermedad renal. OBJETIVO: Evaluar la exactitud del SCC para detectar EAC obstructiva y prever eventos cardiovasculares en candidatos a trasplante renal comparada a la angiograf&#237;a coronaria invasiva (ACI) cuantitativa. M&#201;TODOS: Se evaluaron a 97 pacientes con IRC y edad &gt; 35 a&#241;os. Se consider&#243; como EAC obstructiva la presencia de estenosis &gt; 50% o &gt; 70% por la ACI. Datos descriptivos, concordancia, pruebas diagn&#243;sticas, Kaplan-Meier y an&#225;lisis multivariado se utilizaron. RESULTADOS: El score de Agatston promedio fue de 580,6 &#177; 1.102,2; los valores m&#237;nimos y m&#225;ximos fueron 0 y 7.994, y mediana de 176. Solamente 14 pacientes ten&#237;an score de calcio de cero. No hubo diferencias entre las etnias y la mayor presencia de calcio regional se asoci&#243; a la mayor probabilidad de estenosis coronaria en el mismo segmento. El score de calcio de Agatston present&#243; buena exactitud para el diagn&#243;stico de estenosis, &gt; 50% y &gt; 70% con &#225;rea bajo la curva ROC de 0,75 y 0,70, respectivamente. En el umbral de 400, el score de calcio identific&#243; el subgrupo con mayor tasa de eventos cardiovasculares en tiempo promedio de seguimiento de 29,1 &#177; 11,0 meses. CONCLUSI&#211;N: El SCC en la evaluaci&#243;n de EAC present&#243; una buena performance diagn&#243;stica y pronostica para eventos cardiovasculares en pacientes con insuficiencia renal cr&#243;nica (IRC).</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>Tomograf&#237;a computarizada de emisi&#243;n</kwd>
        <kwd>score de calcio</kwd>
        <kwd>enfermedad de la arteria coronaria</kwd>
        <kwd>insuficiencia renal cr&#243;nica</kwd>
        <kwd>determinaci&#243;n</kwd>
        <kwd>pron&#243;stico</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ART&#205;CULO ORIGINAL</bold>
      </p>
      <p>
        <fn id="top-body2">
          <label>
            <bold>Score de calcio coronario predice estenosis y eventos en la insuficiencia renal cr&#243;nica pre trasplante</bold>
          </label>
          <p>Miguel Abra&#227;o Ros&#225;rio<a href="#back1" link-type="internal"><sup><bold>*</bold></sup></a>; Jos&#233; Jayme de Lima; Jos&#233; R. Parga; Luiz F. &#193;vila; Luis H. Gowdak; Pedro A. Lemos; Carlos E. Rochitte<a href="#back1" link-type="internal"><sup><bold>*</bold></sup></a></p>
        </fn>
      </p>
      <p>Instituto do Cora&#231;&#227;o (InCor) do Hospital das Cl&#237;nicas da Faculdade de Medicina da Universidade de S&#227;o Paulo, S&#227;o Paulo,SP - Brasil</p>
      <p>Correspondencia</p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p><bold>FUNDAMENTO: </bold> La enfermedad arterial coronaria (EAC) es la principal causa de &#243;bito en pacientes con insuficiencia renal cr&#243;nica (IRC). Los ex&#225;menes no invasivos tradicionales para detecci&#243;n de EAC y predicci&#243;n de eventos vienen presentando resultados insuficientes en este grupo. La evaluaci&#243;n del score de calcio coronario (SCC) por tomograf&#237;a computarizada ha estado comprobando valor pron&#243;stico en la poblaci&#243;n sin enfermedad renal.</p>
      <p><bold>OBJETIVO: </bold> Evaluar la exactitud del SCC para detectar EAC obstructiva y prever eventos cardiovasculares en candidatos a trasplante renal comparada a la angiograf&#237;a coronaria invasiva (ACI) cuantitativa.</p>
      <p><bold>M&#201;TODOS: </bold> Se evaluaron a 97 pacientes con IRC y edad <underline>&gt;</underline> 35 a&#241;os. Se consider&#243; como EAC obstructiva la presencia de estenosis <underline>&gt;</underline> 50% o <underline>&gt;</underline> 70% por la ACI. Datos descriptivos, concordancia, pruebas diagn&#243;sticas, Kaplan-Meier y an&#225;lisis multivariado se utilizaron.</p>
      <p><bold>RESULTADOS: </bold> El score de Agatston promedio fue de 580,6 &#177; 1.102,2; los valores m&#237;nimos y m&#225;ximos fueron 0 y 7.994, y mediana de 176. Solamente 14 pacientes ten&#237;an score de calcio de cero. No hubo diferencias entre las etnias y la mayor presencia de calcio regional se asoci&#243; a la mayor probabilidad de estenosis coronaria en el mismo segmento. El score de calcio de Agatston present&#243; buena exactitud para el diagn&#243;stico de estenosis, <underline>&gt;</underline> 50% y <underline>&gt;</underline> 70% con &#225;rea bajo la curva ROC de 0,75 y 0,70, respectivamente. En el umbral de 400, el score de calcio identific&#243; el subgrupo con mayor tasa de eventos cardiovasculares en tiempo promedio de seguimiento de 29,1 &#177; 11,0 meses.</p>
      <p><bold>CONCLUSI&#211;N: </bold> El SCC en la evaluaci&#243;n de EAC present&#243; una buena performance diagn&#243;stica y pronostica para eventos cardiovasculares en pacientes con insuficiencia renal cr&#243;nica (IRC).</p>
      <p><bold>Palabras clave: </bold> Tomograf&#237;a computarizada de emisi&#243;n, score de calcio, enfermedad de la arteria coronaria, insuficiencia renal cr&#243;nica, determinaci&#243;n, pron&#243;stico.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>La enfermedad arterial coronaria (EAC) es la principal causa de &#243;bito en pacientes con insuficiencia renal cr&#243;nica (IRC)<sup>1</sup>. El riesgo de muerte por EAC en este grupo de pacientes es mayor que en la poblaci&#243;n general. Dependiendo del estadio de la IRC<sup>2</sup>, el riesgo cardiovascular puede aumentar significativamente. En los pacientes en di&#225;lisis, en el estadio 5 de la IRC, el riesgo cardiovascular es de 20 a 1.000 veces mayor que en personas de la poblaci&#243;n general sin enfermedad renal, dependiendo de la edad de la poblaci&#243;n estudiada<sup>2</sup>. Entre pacientes en hemodi&#225;lisis o di&#225;lisis peritoneal, la prevalencia de enfermedad coronaria es de cerca del 40%<sup>1</sup>. En los Estados Unidos, cerca del 10% de los pacientes en di&#225;lisis mueren de enfermedad cardiaca cada a&#241;o, y es un consenso que pacientes con IRC se deben considerar como de alto riesgo para el desarrollo de eventos cardiovasculares, adem&#225;s de someterse a la evaluaci&#243;n cardiovascular frecuente<sup>3</sup>. Todav&#237;a en este grupo, la diabetes mellitus impone riesgo de mortalidad semejante al de la EAC.</p>
      <p>Pruebas no invasivas, empleadas en la evaluaci&#243;n de EAC en pacientes con IRC, tienen como objetivos identificar la presencia de EAC y evaluar el riesgo de eventos cardiovasculares y &#243;bito<sup>5</sup>.</p>
      <p>En pacientes con IRC y alto riesgo para EAC, la prevalencia de EAC y la incidencia de eventos adversos cardiovasculares mayores (EACM) son altos. Por tanto, para que mejore el pron&#243;stico es necesaria la b&#250;squeda constante por EAC, a trav&#233;s de los mejores m&#233;todos diagn&#243;sticos disponibles. El servicio especializado en IRC del InCor recientemente identific&#243; que EAC significante y complicaciones cardiovasculares no est&#225;n relacionados con la mayor&#237;a de los factores de riesgo cl&#225;sicos en este grupo espec&#237;fico de pacientes con IRC. Los autores concluyen que pacientes con diabetes, enfermedad arterial perif&#233;rica e infarto previo est&#225;n bajo alto riesgo de EAC, EACM o ambos, y, por tanto, deben ser referidos al procedimiento diagn&#243;stico invasivo<sup>6</sup>. Respecto a estrategias de evaluaci&#243;n de la EAC en estos pacientes y su relaci&#243;n con el pron&#243;stico, De Lima et al<sup>7</sup> publicaron datos conclusivos indicando que el estudio para evaluaci&#243;n de la EAC con mayor poder pron&#243;stico fue la angiograf&#237;a coronaria invasiva (ACI), cuando comparada a pruebas no invasivos (medicina nuclear y ecocardiograf&#237;a de estr&#233;s)<sup>7</sup>. Esto brind&#243; la posibilidad para la investigaci&#243;n de nuevos m&#233;todos de diagn&#243;stico no invasivos, que todav&#237;a no hab&#237;an sido evaluados en este grupo de pacientes con IRC y ven&#237;an revelando un buen desempe&#241;o en pacientes con EAC en la poblaci&#243;n general. Entre estos nuevos m&#233;todos est&#225;n: la resonancia magn&#233;tica cardiovascular y la tomograf&#237;a computarizada de m&#250;ltiples columnas de detectores (TCMD), con evaluaci&#243;n de la calcificaci&#243;n coronaria (score de calcio coronario - SCC) y detecci&#243;n de la estenosis coronaria (angiograf&#237;a coronaria por tomograf&#237;a).</p>
      <p>Uno de los m&#225;s importantes motivos para evaluar la presencia de EAC es el uso de esta informaci&#243;n como dato pron&#243;stico, pudiendo as&#237; tener una estimaci&#243;n de los riesgos individuales de eventos cardiovasculares y ajustar las mediciones terap&#233;uticas y preventivas de forma adecuada al riesgo de determinado paciente. Mientras que la ACI revel&#243; ser un examen pron&#243;stico poderoso<sup>7</sup>, a&#250;n no se probaron las nuevas t&#233;cnicas de TCMD extensamente en pacientes con IRC pre trasplante.</p>
      <p>As&#237;, nuestra hip&#243;tesis fue de que el uso de la TCMD pueda ser &#250;til en el diagn&#243;stico de EAC significativa y en la estimaci&#243;n pronostica en los pacientes con IRC candidatos a trasplante renal. Nuestro objetivo fue investigar si la calcificaci&#243;n coronaria detectada por la TCMD es capaz de predecir la presencia de estenosis coronaria y eventos cardiovasculares en pacientes con IRC.</p>
      <p>
        <bold>M&#233;todos</bold>
      </p>
      <p>Se incluyeron a 97 pacientes con IRC en programa de hemodi&#225;lisis, indicados para someterse a trasplante renal, y con indicaci&#243;n cl&#237;nica de ACI. La indicaci&#243;n cl&#237;nica de ACI se bas&#243; en el hecho de los pacientes pertenecer al grupo de alto riesgo para EAC o por medio de s&#237;ntomas y/o ex&#225;menes no invasivos previos que llevaran la sospecha de EAC. Los pacientes considerados como de alto riesgo fueron aquellos con por lo menos uno de los siguientes criterios: 1) edad <underline>&gt;</underline> 50 a&#241;os; 2) diabetes mellitus; 3) historia o evidencia cl&#237;nica de enfermedad cardiovascular<sup>8</sup>. El reclutamiento se llev&#243; a cabo mediante consultorio especializado en IRC del Servicio de Hipertensi&#243;n del Instituto do Cora&#231;&#227;o de la Facultad de Medicina de la Universidad de S&#227;o Paulo. En este servicio, el manejo de los pacientes de alto riesgo o con sospecha de EAC incluye la ACI debido a su mejor performance pronostica. La TCMD con contraste iodado no i&#243;nico se llev&#243; a cabo tras exclusi&#243;n de contraindicaci&#243;n al estudio y consentimiento informado firmado. Este proyecto se aprob&#243; por la comisi&#243;n de &#233;tica y investigaci&#243;n del InCor y HCFMUSP (CAPEPesq, n&#250;mero 0195/04) y obtuvo soporte financiero de la Fundaci&#243;n de Amparo a la Investigaci&#243;n del Estado de S&#227;o Paulo (FAPESP, proceso n&#250;mero 2004-08363-6). Los criterios de inclusi&#243;n fueron: varones o mujeres; con 35 a&#241;os de edad o m&#225;s; con IRC; en programa de di&#225;lisis y candidatos a trasplante renal; con indicaci&#243;n cl&#237;nica de ACI y con intervalo m&#225;ximo con la TCMD de un a&#241;o (efectuada en hasta un a&#241;o antes de la inclusi&#243;n, como m&#225;ximo, o con la ACI planificada para los pr&#243;ximos meses). Los criterios de exclusi&#243;n fueron: alergia conocida a medio de contraste iodado; fibrilaci&#243;n atrial, taquiarritmia o bloqueo atrioventricular avanzado; evidencia de insuficiencia cardiaca sintom&#225;tica severa (NYHA clase III/IV); estenosis a&#243;rtica conocida; cirug&#237;a cardiaca previa; stent coronario; intolerancia o contraindicaci&#243;n la betabloqueante conocida, como enfermedad pulmonar broncoesp&#225;stica.</p>
      <p>En este estudio, se consider&#243; como EAC significativa la presencia de por lo menos una estenosis <underline>&gt;</underline>50% por paciente, en rama coronaria principal y di&#225;metro luminal mayor que 1,5 mm, identificada por la ACI. Se analizaron tambi&#233;n secundariamente las estenosis <underline>&gt;</underline> 70%, as&#237; como el an&#225;lisis segmentar en estos dos umbrales.</p>
      <p>De los 97 pacientes disponibles para el estudio, 63 (65,0%) eran del sexo masculino y 34 (35,0%) del sexo femenino, con edad promedio &#177; desviaci&#243;n est&#225;ndar de 56,7 &#177; 7,4 (<xref ref-type="table" rid="es_18t01-body2">Tabla 1</xref>). La edad m&#237;nima fue de 35 a&#241;os y la m&#225;xima de 76 a&#241;os.</p>
      <p content-type="asset">
        <table-wrap id="es_18t01-body2">
          <graphic xlink:href="1678-4170-abc-94-02-0252-00018-gt01-es.jpg"/></table-wrap>
      </p>
      <p>La prevalencia de los factores de riesgo tradicionales para EAC fue la siguiente: hipertensi&#243;n arterial sist&#233;mica - 87 (89,6%); diabetes mellitus - 37 (38,1%); dislipidemia - 33 (34,0%); arteriopat&#237;a 33 (34,0%); angina - 28 (28,9%); tabaquismo actual - 20 (20,6%); antecedentes familiares de EAC - 18 (18,6%); accidente cerebrovascular (ACV) - 12 (12,4%); insuficiencia cardiaca congestiva (ICC) - 8 (8,2%); infarto agudo de miocardio (IAM) - 7 (7,2%). Cabe resaltar que los pacientes que presentaron algunos s&#237;ntomas o angina eran todos estables y los s&#237;ntomas fueron posteriores a la indicaci&#243;n de coronariograf&#237;a invasiva. No se incluyeron a pacientes con indicaci&#243;n de coronariograf&#237;a para investigaci&#243;n de dolor tor&#225;cico de inicio reciente (y potencialmente inestables). As&#237;, todos los pacientes incluidos en el protocolo eran asintom&#225;ticos en el momento de la inclusi&#243;n.</p>
      <p>Los datos antropom&#233;tricos de nuestra muestra y la frecuencia cardiaca durante la adquisici&#243;n del examen de tomograf&#237;a est&#225;n detallados en la <xref ref-type="table" rid="es_18t01-body2">Tabla 1</xref>. El promedio del tiempo de di&#225;lisis fue de 40,2 &#177; 42,1 meses, con promedio de 26,5 meses, m&#237;nimo de 2 meses y m&#225;ximo de 240 meses.</p>
      <p>
        <bold>Protocolo de adquisici&#243;n de las im&#225;genes por la TCMD</bold>
      </p>
      <p>Los ex&#225;menes de TCMD se llevaron a cabo en aparatos de 16 y 64 columnas de detectores (<italic>Aquilion16</italic>&#153; y <italic>Aquilion64</italic>&#153; <italic>- Toshiba</italic>&#153; <italic>Medical Systems Corporation</italic>, Otawara, Jap&#243;n) en el Instituto do Cora&#231;&#227;o (InCor - HCFMUSP).</p>
      <p>Se orient&#243; a los pacientes en cuanto a los detalles del examen y se los posicion&#243; en la mesa de la TCMD en posici&#243;n de dec&#250;bito dorsal, desplazados a la derecha, y se mantuvo el coraz&#243;n en el centro del foco de rayos-X. Todos los pacientes recibieron monitorizaci&#243;n electrocardiogr&#225;fica para sincronizaci&#243;n con la adquisici&#243;n de la imagen y seguimiento de la frecuencia cardiaca durante el examen. Los brazos del paciente se posicionaron arriba de la cabeza y con los cables del ECG pasando por fuera del campo de escaneado.</p>
      <p>La frecuencia cardiaca (FC) de los pacientes durante la realizaci&#243;n del examen fue de 61,1 &#177; 6,9 lpm. Los pacientes con frecuencia cardiaca superior a 70 lpm al ingreso a la tomograf&#237;a recibieron betabloqueante endovenoso, metoprolol, en la dosis necesaria para alcanzar la FC blanco de 60 lpm o incluso la dosis m&#225;xima de 15 mg, ya que estos participaron de un protocolo con adquisici&#243;n de angiotomograf&#237;a de coronaria asociado. Las frecuencias cardiacas se midieron siempre durante pausa respiratoria.</p>
      <p>
        <bold>Protocolo de la TCMD - adquisici&#243;n de las im&#225;genes</bold>
      </p>
      <p>Inicialmente, obten&#237;amos la llamada imagen localizadora. As&#237; que una ventana de barredura se visualmente establec&#237;a con base en esta primera imagen, con cobertura desde la bifurcaci&#243;n de la tr&#225;quea (carina) hasta la completa inclusi&#243;n de la silueta cardiaca. Esta planificaci&#243;n se utiliz&#243; para la adquisici&#243;n del score de calcio.</p>
      <p>As&#237; que el score de calcio se obtuvo a trav&#233;s de la adquisici&#243;n prospectiva y sincronizada al trazado de ECG. Las im&#225;genes se adquirieron con espesor de corte de 3,0 mm y campo de visi&#243;n de 200 a 220 mm, para la obtenci&#243;n de im&#225;genes axiales del t&#243;rax que cubren toda el &#225;rea card&#237;aca y permite la visualizaci&#243;n de las arterias coronaria y de la eventual calcificaci&#243;n en topograf&#237;a de las mismas. Las im&#225;genes se adquirieron en momento diast&#243;lico definido de acuerdo con la frecuencia cardiaca del paciente. La adquisici&#243;n del score de calcio necesit&#243; pausa inspiratoria promedio de cerca de 15 s, de acuerdo con el protocolo ya validado<sup>9</sup>. Los par&#225;metros de adquisici&#243;n del score de calcio fueron: velocidad de rotaci&#243;n del tubo de 0.75 s, colimaci&#243;n de los detectores 4 por 3.0 mm, voltaje del tubo de 120 kV, y corriente del tubo de 300 mA.</p>
      <p>
        <bold>Adquisici&#243;n de la angiograf&#237;a coronaria invasiva</bold>
      </p>
      <p>Las angiograf&#237;a coronaria se llevaron a cabo de acuerdo con las t&#233;cnicas ya consagradas y estandarizadas en la rutina del servicio de hemodin&#225;mica del Instituto do Cora&#231;&#227;o (InCor) HC-FMUSP<sup>10</sup> y con indicaci&#243;n cl&#237;nica independiente del protocolo de investigaci&#243;n.</p>
      <p>
        <bold>Seguimiento de los eventos cardiovasculares</bold>
      </p>
      <p>Los datos de seguimiento se obtuvieron de una de las tres fuentes, como m&#237;nimo: 1) consulta de rutina en el consultorio especializado, 2) llamada para el paciente o pariente para cuestionar sobre el estado de salud del paciente o 3) revisi&#243;n del prontuario del paciente. En nuestro protocolo, se consideraron como eventos cardiovasculares: muerte cardiaca (definida por dos cardi&#243;logos en consenso tras revisi&#243;n de los datos disponibles); infarto agudo de miocardio (elevaci&#243;n enzim&#225;tica 3x el valor normal, asociada a cuadro agudo de dolor tor&#225;cico y/o alteraci&#243;n del ECG compatible con isquemia mioc&#225;rdica); accidente cerebrovascular (diagn&#243;stico cl&#237;nico o por m&#233;todo de imagen); enfermedad vascular perif&#233;rica severa o gangrena (isquemia de miembros severa que conllev&#243; el procedimiento quir&#250;rgico asociado); angina inestable (dolor tor&#225;cico t&#237;pico, alteraci&#243;n de ECG compatible con isquemia mioc&#225;rdica en pacientes con probabilidad como m&#237;nimo intermediaria de EAC); insuficiencia cardiaca congestiva (diagn&#243;stico cl&#237;nico y ecocardiograma indicando reducci&#243;n de la fracci&#243;n de eyecci&#243;n del VI); y edema agudo de pulm&#243;n (diagn&#243;stico cl&#237;nico y radiograf&#237;a del t&#243;rax evidenciando edema pulmonar intersticial).</p>
      <p>
        <bold>An&#225;lisis de datos</bold>
      </p>
      <p>
        <bold>An&#225;lisis del score de calcio</bold>
      </p>
      <p>Scores de calcio total, seg&#250;n el m&#233;todo descrito por Agatston et al<sup>9</sup>, se obtuvieron para cada paciente (<xref ref-type="fig" rid="f1-body2">Figura 1</xref>) en <italic>workstation Vitrea</italic>&#153;2, versi&#243;n 3,5 <italic>- Vital Images Inc</italic>, Plymouth, MN, EUA. En el an&#225;lisis de las im&#225;genes de score de calcio, utilizamos dos mediciones: la del score de Agatston<sup>9</sup> y la del volumen de calcio. El score de Agatston viene siendo el m&#225;s utilizado en la literatura y mantiene relaci&#243;n con la enfermedad coronaria y aun con EAC obstructiva cuando en niveles muy elevados (percentil arriba del 75% o el 90%).</p>
      <fig id="f1-body2">
        <graphic xlink:href="1678-4170-abc-94-02-0252-00018-gf01-es.jpg"/></fig>
      <p>
        <bold>Angiograf&#237;a coronaria cuantitativa o QCA</bold>
      </p>
      <p>Un observador experimentado en la t&#233;cnica de QCA y que no particip&#243; del an&#225;lisis de la TCMD, tambi&#233;n de forma ciega e independiente, analiz&#243; todas las ACI y aplic&#243; la t&#233;cnica de la <italic>QCA</italic> (<italic>Coronary Analysis Angiographic System - CASS II</italic>, <italic>Pie Medical Imaging BV</italic>&#153;, <italic>Maastricht, The Netherlands</italic>)<sup>11-14</sup>.</p>
      <p>As&#237;, el di&#225;metro de cada estenosis, que se considera como visualmente intermediaria como m&#237;nimo (<underline>&gt;</underline> 50%), se design&#243; objetivamente en valores porcentuales relativos al llamado "di&#225;metro de referencia" (di&#225;metro del segmento del mismo vaso que se encontraba libre de enfermedad y estaba en posici&#243;n inmediatamente proximal a la lesi&#243;n), y se determin&#243; en dos direcciones ortogonales, con el promedio entre ellos estableciendo la severidad final de la estenosis.</p>
      <p>Todas las lesiones con di&#225;metro de referencia <underline>&gt;</underline> 1,5 mm se incluyeron en el an&#225;lisis comparativo de este estudio. En caso de que el mismo segmento de la arteria principal o rama de primera orden tenga m&#225;s de una estenosis significativa, solamente la estenosis m&#225;s severa se comparaba a su correspondiente por la TCMD<sup>10,15,16</sup>.</p>
      <p>
        <bold>An&#225;lisis estad&#237;stico</bold>
      </p>
      <p>Las variables descriptivas se expresaron como promedios y una desviaci&#243;n est&#225;ndar y medianas, si apropiado. Por haber presentado una curva de distribuci&#243;n asim&#233;trica, los niveles de calcificaci&#243;n arterial coronaria se expresaron a trav&#233;s de sus medianas, percentiles y valores extremos.</p>
      <p>A fin de establecer las mediciones de exactitud diagn&#243;stica de la TCMD, echamos mano de una cl&#225;sica tabla 2x2.</p>
      <p>La prueba exacto de Fisher se utiliz&#243; para calcular las mediciones de exactitud diagn&#243;stica de la TCMD, comparada a la QCA, en lo que toca a la identificaci&#243;n de estenosis coronaria con di&#225;metro <underline>&gt;</underline> 50% y <underline>&gt;</underline> 70%. Para comparaci&#243;n de los diferentes scores de calcio coronario obtenidos por la TCMD en los respectivos territorios, utilizamos la prueba de Mann-Whitney.</p>
      <p>No se utilizaron a&#250;n las curvas de Kaplan-Meier para el an&#225;lisis de tasa de eventos en el tiempo en diversos subgrupos. Todos los an&#225;lisis realizados en el programa estad&#237;stico Stata&#153;/SE 8 (<italic>StataCorp LP, College Station, TX</italic>).</p>
      <p>
        <bold>Resultados</bold>
      </p>
      <p>Nuestra muestra de pacientes con IRC present&#243; score de Agatston promedio de 580,6 &#177; 1.102,2. Los valores m&#237;nimos y m&#225;ximos fueron 0 y 7.994. De los 97 pacientes con score de calcio analizados, solamente 14 pacientes no ten&#237;an ninguna calcificaci&#243;n coronaria detectable, es decir, score de calcio de cero. Se presentan tambi&#233;n en la <xref ref-type="table" rid="es_18t02-body2">Tabla 2</xref> los valores de score y volumen total para todo el &#225;rbol coronario y para cada territorio coronario espec&#237;fico, con sus promedios, desviaciones est&#225;ndar, mediana, valores m&#237;nimos y m&#225;ximos en cada categor&#237;a. Los valores de los percentiles para edad y sexo se hallaron en la <xref ref-type="table" rid="t3-body2">Tabla 3</xref>. Los valores promedios de los percentiles para edad, sexo y etnia, basado en el estudio <italic>MESA</italic> (<italic>Multiethnic Study of Atherosclerosis</italic>) son referidos como MESA, en la <xref ref-type="table" rid="t3-body2">Tabla 3</xref>.</p>
      <p content-type="asset">
        <table-wrap id="es_18t02-body2">
          <graphic xlink:href="1678-4170-abc-94-02-0252-00018-gt02-es.jpg"/></table-wrap>
      </p>
      <table-wrap id="t3-body2">
        <graphic xlink:href="1678-4170-abc-94-02-0252-00018-gt03-es.jpg"/></table-wrap>
      <p>La distribuci&#243;n del SCC es significativamente asim&#233;trica, siendo as&#237;, relatamos la mediana del score total de Agatston y su distribuci&#243;n por percentiles (<xref ref-type="table" rid="t3-body2">Tabla 3</xref>).</p>
      <p>Con relaci&#243;n a la etnia de los pacientes, no hubo diferencia significativa de los SCCs promedios entre los grupos &#233;tnicos: blancos (698,5 &#177; 1.309, mediana 205, n = 64); negros (389,0 &#177; 761,80, mediana 158, n = 10); orientales (728,1 &#177; 1.045, mediana 272,5, n = 8); pardos o mestizos (217,3 &#177; 350,0, mediana 37, n = 22); con p = 0,36 por la prueba no param&#233;trica de Kruskal-Wallis.</p>
      <p>
        <bold>Score de calcio <italic>versus</italic> estenosis coronaria</bold>
      </p>
      <p>Comparamos el grado de calcificaci&#243;n entre los pacientes con o sin coronariopat&#237;a obstructiva significativa (estenosis <underline>&gt;</underline> 70%). Por el cateterismo se demostr&#243; que el score de Agatston es significativamente mayor en el grupo con EAC significativa en el cateterismo, por la prueba de Wilcoxon (<xref ref-type="table" rid="es_18t02-body2">Tabla 2</xref>). El tiempo trascurrido entre la realizaci&#243;n de la TCMD y de la ACI fue de cerca de 99,03 d&#237;as con desviaci&#243;n est&#225;ndar de 87,65 d&#237;as y mediana de 79 d&#237;as. El intervalo m&#237;nimo fue de 2 d&#237;as y el m&#225;ximo de 380 d&#237;as, con solamente 2 casos superior a un a&#241;o y 16 casos con intervalo superior a seis meses.</p>
      <p>Evaluamos el porcentual de pacientes con estenosis coronaria <underline>&gt;</underline> 50% y <underline>&gt;</underline> 70% por la ACI en los diversos extractos de SCC. Observamos un crecimiento progresivo, lineal y significativo entre el porcentaje de pacientes con EAC y el grado de calcificaci&#243;n coronaria (<xref ref-type="fig" rid="f2-body2">Figura 2</xref>). Los pacientes con estenosis por la ACI <underline>&gt;</underline> 50% fueron 55/97 (57%) y los pacientes con estenosis <underline>&gt;</underline> 70% fueron 25/97 (26%).</p>
      <fig id="f2-body2">
        <graphic xlink:href="1678-4170-abc-94-02-0252-00018-gf02-es.jpg"/></fig>
      <p>En el an&#225;lisis de la calcificaci&#243;n coronaria <italic>versus</italic> la ACI, observamos que para estenosis <underline>&gt;</underline> 50% y <underline>&gt;</underline> 70%, el umbral de 400 de score de Agatston se asoci&#243; estad&#237;sticamente la mayor proporci&#243;n de pacientes con estenosis significantes (p &lt; 0,001, por el chi-cuadrado, <xref ref-type="fig" rid="f2-body2">figura 2</xref>).</p>
      <p>El an&#225;lisis regional del score de calcio tambi&#233;n revel&#243; las mismas diferencias observadas para el score global, a excepci&#243;n del TCE. As&#237;, los scores regionales fueron significativamente mayores en segmentos con estenosis <underline>&gt;</underline> 50% y el 70% cuando comparados con aquellos segmentos sin estenosis.</p>
      <p>La exactitud del score de calcio para diagnosticar la estenosis coronaria tambi&#233;n se evalu&#243; mediante el uso del percentil del estudio <italic>MESA</italic> en el umbral del percentil 75, y est&#225; detallada en la <xref ref-type="table" rid="es_18t04-body2">Tabla 4</xref>.</p>
      <p content-type="asset">
        <table-wrap id="es_18t04-body2">
          <graphic xlink:href="1678-4170-abc-94-02-0252-00018-gt04-es.jpg"/></table-wrap>
      </p>
      <p>Teniendo en cuenta los 14 pacientes con score y calcio cero: cuatro (28%) presentaron estenosis <underline>&gt;</underline> 50% en la ACI y solamente dos (14%) estenosis <underline>&gt;</underline> 70%. Al utilizar el score de calcio de forma binaria, igual a cero o mayor que cero, para predecir la estenosis coronaria, obtuvimos en nuestra muestra un valor predictivo negativo del 71% para la estenosis <underline>&gt;</underline> 50% y el 86% para la estenosis <underline>&gt;</underline> 70%.</p>
      <p>
        <bold>Score de calcio - capacidad predictiva de la estenosis coronaria</bold>
      </p>
      <p>Investigamos, con la utilizaci&#243;n de la regresi&#243;n log&#237;stica y la construcci&#243;n de curvas ROC (<italic>receiver-operating characteristics</italic>), si el score de calcio consigue prever la presencia de estenosis coronaria en la ACI.</p>
      <p>Evaluamos la exactitud del score de calcio por el an&#225;lisis de la curva ROC tanto para el umbral de estenosis del 50% (&#225;rea bajo la curva de 0,75) como del 70% (&#225;rea bajo la curva de 0,70), definidos por la ACI (<xref ref-type="fig" rid="es_18f03-body2">figura 3</xref>, painel A para el umbral del 50% y B para el umbral del 70%).</p>
      <p content-type="asset">
        <fig id="es_18f03-body2">
          <graphic xlink:href="1678-4170-abc-94-02-0252-00018-gf03-es.jpg"/></fig>
      </p>
      <p>Basado en la regresi&#243;n log&#237;stica y en las curvas ROC detalladas arriba, podemos afirmar que el score de calcio consigue prever la presencia de una estenosis coronaria <underline>&gt;</underline> 50% por la ACI, en el mejor umbral de 186,53, con exactitud del 66%, sensibilidad del 65%, especificidad del 66%, valor predictivo positivo del 72%, y valor predictivo negativo del 60% (p = 0,01).</p>
      <p>De igual manera, el score de calcio consigue prever la presencia de una estenosis coronaria <underline>&gt;</underline> 70% por la ACI, en el mejor umbral de 1.330,72, con exactitud del 65%, sensibilidad del 64%, especificidad del 65%, valor predictivo positivo del 39%, y valor predictivo negativo del 84% (p = 0,01).</p>
      <p>Los umbrales detallados arriba tambi&#233;n fueron aquellos que presentaron los mejores valores predictivos negativos posibles, lo que puede responder la cuesti&#243;n de qu&#233; nivel de score de calcio puede prever la ausencia de estenosis significativa.</p>
      <p>
        <bold>Score de calcio <italic>versus</italic> eventos cardiovasculares</bold>
      </p>
      <p>El tiempo promedio de seguimiento para evaluaci&#243;n de eventos en nuestra poblaci&#243;n fue de 29,1 &#177; 11,0 meses, con mediana de 31 meses y seguimiento m&#237;nimo de 3 meses y m&#225;ximo de 43 meses. Los eventos observados y sus frecuencias absolutas fueron: infarto agudo de miocardio (ocho), accidente cerebrovascular (cinco), enfermedad vascular perif&#233;rica severa o gangrena (cuatro), angina inestable (dos), muerte s&#250;bita (dos), insuficiencia cardiaca congestiva (una) y edema agudo de pulm&#243;n (un). El total de eventos fue de 23. Teniendo en cuenta los 97 pacientes, 23 casos presentaron eventos, totalizando un 23,7% de nuestra muestra. No presentaron eventos 71 pacientes y hubo p&#233;rdida de seguimiento en tres casos.</p>
      <p>Con relaci&#243;n a la predicci&#243;n de eventos que el SCC pudiera tener en esta poblaci&#243;n, observamos que el percentil del estudio MESA de esta poblaci&#243;n no fue predictivo significativamente de eventos, tanto en el umbral del 75% como en el umbral del 90%.</p>
      <p>Todav&#237;a en el an&#225;lisis de eventos, probamos el score de calcio como predictor de eventos en varios umbrales de corte: 0 (presencia o ausencia), 10, 100 y 400. El umbral de score de calcio de 400 mostr&#243; curvas de Kaplan-Meier con tasa de eventos significativamente diferentes, detallada en la <xref ref-type="fig" rid="f4-body2">Figura 4</xref>.</p>
      <fig id="f4-body2">
        <graphic xlink:href="1678-4170-abc-94-02-0252-00018-gf04-es.jpg"/></fig>
      <p>
        <bold>Discusi&#243;n</bold>
      </p>
      <p>Este fue el primer trabajo a evidenciar que la TCMD suministra informaciones pronostica en los pacientes con IRC, candidatos a trasplante renal.</p>
      <p>El SCC present&#243; correlaci&#243;n con la presencia de estenosis y buen desempe&#241;o diagn&#243;stico con relaci&#243;n a la ACI para detecci&#243;n de estenosis, y mostr&#243; poder pron&#243;stico para el nivel de corte de 400 de score Agatston en nuestra poblaci&#243;n.</p>
      <p>Se observaron scores promedios bastante elevados. Scores superior a 300 &#243; 400 se relatan en la literatura en pacientes sin IRC como siendo asociados a la alta probabilidad de EAC obstructiva y al alto riesgo de eventos cardiovasculares<sup>17,18</sup>. En los pacientes con IRC dial&#237;tica, se relata una magnitud 2,5 veces mayor de calcificaci&#243;n coron&#225;ria<sup>19-22</sup>, aunque esta calcificaci&#243;n aumentada se relaciones m&#225;s a los factores de riesgo tradicionales para EAC aumentados en esta poblaci&#243;n, que a factores relacionados a la funci&#243;n renal o a la di&#225;lisis<sup>23</sup>. Se describe una calcificaci&#243;n vascular relacionada a la di&#225;lisis, llamada arteriopat&#237;a ur&#233;mica, caracterizada por calcificaci&#243;n difusa de la camada promedio de arterias de peque&#241;o a mediano di&#225;metro y arteriolas, con proliferaci&#243;n intimal y trombosis, que puede causar &#250;lceras y necrosis de piel. Lo cuanto este mecanismo puede influir en la calcificaci&#243;n de las arterias coronarias en este grupo de pacientes no est&#225; completamente clarificado<sup>24</sup>.</p>
      <p>Aunque se nota en pacientes de la poblaci&#243;n general una correlaci&#243;n solo parcial entre la calcificaci&#243;n y la obstrucci&#243;n coronaria<sup>18</sup>, hubo una correlaci&#243;n y exactitud diagn&#243;sticas buenas entre el score de calcio y la estenosis coronaria por la TCMD y la ACI en el grupo de pacientes con IRC. El percentil del 75% del estudio MESA revel&#243; sensibilidad del 82% y el 84% para detecci&#243;n de EAC con lesi&#243;n obstructiva <underline>&gt;</underline> 50% y el 70%, respectivamente. Este resultado nos parece extremamente estimulante del uso de esta t&#233;cnica sencilla, con baja radiaci&#243;n y sin uso de contraste. Estos niveles de sensibilidad no se alcanzan habitualmente, ni mismo por ex&#225;menes con estr&#233;s farmacol&#243;gico, como la centellograf&#237;a y el ecocardiograma. En un estudio de nuestro grupo, al utilizar la resonancia magn&#233;tica cardiovascular con estr&#233;s con dipiridamol y la centellograf&#237;a, obtuvimos sensibilidad del 84% y el 66%, respectivamente, en este grupo de pacientes<sup>25</sup>. No obstante, tanto la resonancia como los otros m&#233;todos de estr&#233;s son ex&#225;menes m&#225;s complejos, demorados, dispendiosos, y con mayor riesgo para el paciente que el score de calcio.</p>
      <p>La utilizaci&#243;n del score de calcio absoluto evidenci&#243; valores de sensibilidad menores que aquello alcanzado por el percentil 75%. As&#237;, concluimos que el uso del percentil 75% del estudio MESA fue m&#225;s exacto para la detecci&#243;n de EAC que el score de calcio en n&#250;mero absoluto. La mejor exactitud del score de calcio absoluto para detecci&#243;n de estenosis <underline>&gt;</underline> 50% en la ACI fue de 186. Estos valores umbrales presentaron el mejor valor predictivo negativo posible en esta muestra, y de esta forma, nuestros datos indican que un score de calcio &lt; 186 o abajo del percentil 75% puede alejar la sospecha de estenosis coronaria significativa con probabilidad pr&#243;xima al 90% en este grupo de pacientes.</p>
      <p>As&#237;, la utilidad del score de calcio parece ser todav&#237;a m&#225;s significativa en el grupo de pacientes con IRC. Esta correlaci&#243;n se mostr&#243; verdadera tanto para el score de Agatston global como regional. Se puede acordar todav&#237;a que, en pacientes con alto grado de calcificaci&#243;n, la angiotomograf&#237;a de coronaria puede ser limitada en la evaluaci&#243;n de la reducci&#243;n luminal, aunque t&#233;cnicas especiales y observadores experimentados puedan volver esta evaluaci&#243;n &#250;til cl&#237;nicamente<sup>26</sup>.</p>
      <p>Los datos de la literatura vienen se&#241;alando el score de calcio mucho m&#225;s como predictor de eventos cardiovasculares que de la estenosis coronaria en pacientes de la poblaci&#243;n general<sup>17</sup>. El estudio MESA recientemente ha confirmado este dato en las variadas etnias<sup>27</sup>, lo que reforz&#243; el rol pron&#243;stico del score de calcio. En nuestro estudio, la correlaci&#243;n del calcio con eventos en los pacientes con IRC se hall&#243; significativa para el nivel de 400 de score de Agatston, lo que sugiere que &#233;ste pueda usarse como un umbral de predicci&#243;n pronostica. As&#237;, nuestros datos sugieren que, en el grupo de pacientes con IRC, el score de calcio tiene valor predictivo no solo para eventos, sino tambi&#233;n para la detecci&#243;n de estenosis coronaria, diferentemente de la poblaci&#243;n general. En este aspecto, una limitaci&#243;n de este estudio fue la presencia de siete pacientes con infarto mioc&#225;rdico previo, lo que puede haber elevado el poder diagn&#243;stico de la prueba en esta poblaci&#243;n. Sin embargo, en an&#225;lisis de sensibilidad, excluy&#233;ndose estos pacientes, no hubo alteraci&#243;n significativa en la performance diagn&#243;stica del score de calcio en nuestro grupo.</p>
      <p>Por otra parte, nuestro estudio utiliz&#243; una metodolog&#237;a avanzada, recientemente descripta para la segmentaci&#243;n del &#225;rbol coronaria y an&#225;lisis estad&#237;stico<sup>28</sup>, que representa una evoluci&#243;n en el m&#233;todo cient&#237;fico en este campo y se utiliz&#243; por nosotros en estudio multic&#233;ntrico de gran impacto<sup>29</sup>.</p>
      <p>Algunas importantes implicaciones de uso cl&#237;nico pueden derivarse de nuestros resultados en asociaci&#243;n con los datos de la literatura y de nuestro grupo.</p>
      <p>Teniendo en cuenta el alto &#237;ndice de ACI en la que el resultado es ausencia de EAC o EAC no obstructiva (aproximadamente el 40%)<sup>30</sup>, asociado a las caracter&#237;sticas de excelente perfil de seguridad del score de calcio, su bajo coste y la buena sensibilidad evidenciada por nuestros resultados en los pacientes con IRC, se sugiere que este pueda ser un instrumento con una buena relaci&#243;n coste-efectividad en la detecci&#243;n de EAC. La evaluaci&#243;n de la relaci&#243;n coste-efectividad no fue objetivo de este trabajo, siendo que este dato precisa ser investigado por trabajos futuros, directamente volcados hacia este an&#225;lisis.</p>
      <p>
        <bold>Conclusi&#243;n</bold>
      </p>
      <p>Podemos afirmar que el score de calcio por la tomograf&#237;a computarizada present&#243; buena capacidad diagn&#243;stica para predecir estenosis coronaria (percentil 75 o 186 en el valor absoluto), y pronostica en la predicci&#243;n de eventos cardiovasculares (en el valor absoluto de 400) en pacientes con insuficiencia renal.</p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiaci&#243;n</bold>
      </p>
      <p>El presente estudio fue financiado por la FAPESP y Fundaci&#243;n Zerbini.</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>Este art&#237;culo forma parte de tesis de Doctorado de Miguel Abra&#227;o Ros&#225;rio, por el Instituto do Cora&#231;&#227;o (Incor) - Hospital de Cl&#237;nicas de la Facultad de Medicina de la Universidad de S&#227;o Paulo.</p>
      <p>
        <bold>Referencias</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Coronary calcium score as predictor of stenosis and events in pretransplant renal chronic failure</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: Coronary artery disease (CAD) is the major cause of death among chronic renal failure (CRF) patients. Traditional, non-invasive exams to detect CAD and to predict events have shown insufficient results in this group. CT Scan evaluation of Coronary Calcium Score (CCS) has proven to be of prognostic value for the population reporting no renal condition. OBJECTIVE: To investigate CCS accuracy in detecting obstructive CAD and in predicting cardiovascular events in candidates to renal transplant as compared to quantitative invasive coronary angiography (ICA). METHODS: Ninety-seven (97) CRF patients aged &gt; 35 were evaluated. Obstructive CAD was considered as &gt;50% or &gt;70% stenosis on ICA. Descriptive data, concordance, diagnostic tests, Kaplan-Meier, and multivariate analysis were used. RESULTS: Agatston mean score was 580.6 &#177; 1,102.2. Minimum and maximum values were 0 and 7,994, with median at 176. Only 14 patients had zero calcium score. No differences were reported in regard to ethnicity. Highest regional calcium was associated to the highest probability of coronary stenosis in the same segment. Agatston calcium score showed high accuracy for the diagnosis of &gt;50% and &gt;70% stenosis, with area under ROC curve (AUC) of 0.75 and 0.70, respectively. At the threshold of 400, calcium score identified a subgroup with a higher rate of cardiovascular events at an average follow-up time of 29&#177;11.0 months. CONCLUSION: CCS proved to have good diagnostic and prognostic performance for cardiovascular events evaluation in CRF patients.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Tomography</kwd>
        <kwd>emission-computed</kwd>
        <kwd>calcio score</kwd>
        <kwd>coronary artery disease</kwd>
        <kwd>renal insufficiency</kwd>
        <kwd>chronic</kwd>
        <kwd>determination</kwd>
        <kwd>prognostic</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ORIGINAL ARTICLE</bold>
      </p>
      <p>
        <fn id="top-body3">
          <label>
            <bold>Coronary calcium score as predictor of stenosis and events in pretransplant renal chronic failure</bold>
          </label>
          <p>Miguel Abra&#227;o Ros&#225;rio<a href="#back1" link-type="internal"><sup><bold>*</bold></sup></a>; Jos&#233; Jayme de Lima; Jos&#233; R. Parga; Luiz F. &#193;vila; Luis H. Gowdak; Pedro A. Lemos; Carlos E. Rochitte <a href="#back1" link-type="internal"><sup><bold>*</bold></sup></a></p>
        </fn>
      </p>
      <p>Instituto do Cora&#231;&#227;o (InCor) do Hospital das Cl&#237;nicas da Faculdade de Medicina da Universidade de S&#227;o Paulo, S&#227;o Paulo,SP - Brazil</p>
      <p>Mailing address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p><bold>BACKGROUND: </bold> Coronary artery disease (CAD) is the major cause of death among chronic renal failure (CRF) patients. Traditional, non-invasive exams to detect CAD and to predict events have shown insufficient results in this group. CT Scan evaluation of Coronary Calcium Score (CCS) has proven to be of prognostic value for the population reporting no renal condition.</p>
      <p><bold>OBJECTIVE:</bold> To investigate CCS accuracy in detecting obstructive CAD and in predicting cardiovascular events in candidates to renal transplant as compared to quantitative invasive coronary angiography (ICA).</p>
      <p><bold>METHODS:</bold> Ninety-seven (97) CRF patients aged <underline>&gt;</underline> 35 were evaluated. Obstructive CAD was considered as <underline>&gt;</underline>50% or <underline>&gt;</underline>70% stenosis on ICA. Descriptive data, concordance, diagnostic tests, Kaplan-Meier, and multivariate analysis were used.</p>
      <p><bold>RESULTS:</bold> Agatston mean score was 580.6 &#177; 1102.2. Minimum and maximum values were 0 and 7994, with median at 176. Only 14 patients had zero calcium score. No differences were reported in regard to ethnicity. Highest regional calcium was associated to the highest probability of coronary stenosis in the same segment. Agatston calcium score showed high accuracy for the diagnosis of <underline>&gt;</underline>50% and <underline>&gt;</underline>70% stenosis, with area under ROC curve (AUC) of 0.75 and 0.70, respectively. At the threshold of 400, calcium score identified a subgroup with a higher rate of cardiovascular events at an average follow-up time of 29&#177;11.0 months.</p>
      <p><bold>CONCLUSION: </bold> CCS proved to have good diagnostic and prognostic performance for cardiovascular events evaluation in CRF patients.</p>
      <p><bold>Key Words:</bold> Tomography, emission-computed; calcio score; coronary artery disease; renal insufficiency, chronic; determination; prognostic.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>Coronary Artery Disease (CAD) is the major cause of death among chronic renal failure (CRF) patients<sup>1</sup>. The risk of death from CAD in this group of patients is higher than in the general population. Depending on CRF stage<sup>2</sup>, cardiovascular risk may be significantly increased. Depending on the population under study, patients on dialysis - CRF stage 5 - cardiovascular risk is reported to be from 20 to 1,000 times higher than for the general population with no renal condition<sup>2</sup>. Among patients on hemodialysis or peritoneal dialysis coronary disease prevalence is approximately 40%<sup>1</sup>. In the United States, 10% of all patients on dialysis die from heart diseases every year. It has been consensual that CRF patients must be considered as high risk for the development of cardiovascular events. Therefore, they are to be submitted to frequent cardiovascular evaluation<sup>3</sup>. In the same group, diabetes mellitus poses a mortality risk level similar to that posed by CAD<sup>4</sup>.</p>
      <p>Non-invasive tests used for CAD evaluation in CRF patients have the purpose of identifying CAD condition and evaluating the risk of cardiovascular events and death<sup>5</sup>.</p>
      <p>In patients with CRF and high risk for CAD, the prevalence of CAD and the incidence of major adverse cardiovascular events (MACE) are high. Therefore, the best diagnostic methods available are to be used in order to reach improved prognostics for CAD. At InCor (Instituto do Cora&#231;&#227;o - Heart Institute, S&#227;o Paulo, Brazil) the specialized CRF service found that significant CAD as well as cardiovascular complications are not associated to most classic risk factors in this specific group of CRF patients. The authors conclude that patients presenting diabetes, peripheral artery disease, and previous infarction are under high risk of CAD, MACE, or both. Therefore, they must be submitted to invasive diagnostic procedure<sup>6</sup>. As for CAD evaluation strategies for those patients and their association to prognosis, De Lima et al<sup>7</sup> have published conclusive data showing that invasive coronary angiography (ICA) proved to be of higher prognostic value for CAD evaluation when compared to non-invasive tests (nuclear medicine and stress ECG)<sup>7</sup>. That paved the way for the investigation of new non-invasive diagnostic methods not yet under use for this group of CRF patients and which had been showing good performance in CAD patients in the general population. Among those new methods are the following: cardiovascular MRI and multi-detector CT (MDCT), to evaluate coronary calcium score and to detect coronary stenosis (CT coronary angiogram).</p>
      <p>One of the key reasons to evaluate the presence of CAD is to use that information as prognostic data, since the information provides an estimate of individual risks to cardiovascular events and the adjustment of proper therapeutic and preventive actions against the risks posed to a specific patient. While ICA has proven to be a very effective prognostic exam<sup>7</sup>, the new MDCT techniques have not been extensively tested in pretransplant CRF patients.</p>
      <p>Therefore, our assumption was that MDCT may be useful for the diagnosis of significant CAD as well as for prognostic estimate in CRF patients who are candidates for renal transplant. Our objective was to investigate whether coronary calcification detected by MDCT can be a predictor for coronary stenosis and cardiovascular events in CRF patients.</p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>Ninety-seven (97) CRF patients already in a hemodialysis program and referred to to be submitted to renal transplant, and with clinical indication for ICA were included. The clinical indication for ICA was based on the fact that the patients belonged to the group under high risk for CAD either due to symptoms and/or previous invasive exams that would lead to a suspicion of CAD. Patients considered high risk were those who presented at least one of the following criteria:</p>
      <p>1) Age <underline>&gt;</underline>50;</p>
      <p>2) <italic>Diabetes mellitus</italic>;</p>
      <p>3) history or clinical evidence of cardiovascular disease<sup>8</sup>. Screening was done by the CRF specialized outpatient unit at the Hypertension Service, Heart Institute, University of S&#227;o Paulo at S&#227;o Paulo. In that service, the management of high risk patients or patients with suspicion of CAD includes ICA for its better prognostic performance<sup>7</sup>. Nonionic iodinated contrast was performed after the exclusion of contra-indication to the study and after the informed consent was signed. The project was approved by the Ethics and Research Committee at InCor and HCFMUSP (Medical School Clinics Hospital, University of S&#227;o Paulo - CAPEPesq, 0195/04) and was sponsored by the State of S&#227;o Paulo (FAPESP, 2004-08363-6). Inclusion criteria included: males or females who were 35 years old or older and with CRF and on a dialysis program, candidates for renal transplant, and with clinical indication for ICA, with a 1-year maximum MDCT interval (performed 1 year at maximum before the inclusion, or with ICA planned for the following months). Exclusion criteria included: known allergy to iodinated contrast media; atrial fibrillation, tachyarrhythmia or advanced atrioventricular block; evidence of symptomatic, severe heart failure (NYHA class III/IV); known aortic stenosis; previous heart surgery; coronary stent; known intolerance or contra-indication to beta-blockers, such as bronchospastic pulmonary disease.</p>
      <p>For the purpose of the present study, <underline>&gt;</underline>50% stenosis stood for significant CAD in major coronary branch, with luminal diameter larger than 1.5 mm as identified on ICA. Secondary analysis also focused <underline>&gt;</underline>70% stenosis, as well as segmental analysis in those 2 threshold levels.</p>
      <p>From the 97 patients available for the study, 63 (65.0%) were males and 34 (35.0%) were females. Mean age &#177; SD was 56.7&#177;7.4 (<xref ref-type="table" rid="t1-body3">Table 1</xref>). Minimum age was 35 and maximum, 76.</p>
      <table-wrap id="t1-body3">
        <graphic xlink:href="1678-4170-abc-94-02-0252-00018-gt01-en.jpg"/></table-wrap>
      <p>Prevalence of traditional risk factors for CAD was the following: Systemic arterial hypertension - 87 (89.6%), diabetes mellitus - 37 (38.1%), dyslipidemia - 33 (34.0%), arteriopathy 33(34.0%), angina - 28 (28.9%), current smoking habits - 20 (20.6%), family history of CAD - 18 (18.6%), CVA - 12 (12.4%), CHF - 8 (8.2%), AMI - 7 (7.2%). It should be pointed out that patients who presented any symptom or angina were all stable, and the symptoms had occurred after to the indication for invasive coronariography. No patients with indication for coronariography to investigate recent onset chest pain (and potentially unstable) were included. Therefore, all patients included in the Protocol were asymptomatic at the time of inclusion.</p>
      <p>The anthropometric data from our sample, as well as heart rate (HR) at the time of CT are detailed in <xref ref-type="table" rid="t1-body3">Table 1</xref>. Dialysis mean time was 40.2&#177;42.1 months, with 26.5 months as median, for a minimum time of 2 months and a maximum time of 240 months.</p>
      <p>
        <bold>Image acquisition protocol by <italic>MDCT.</italic></bold>
      </p>
      <p>MDCT exams were performed in 16 and 64-column detector-row (<italic>Aquilion16</italic>&#153; and <italic>Aquilion64</italic>&#153; <italic>- Toshiba</italic>&#153; <italic>Medical Systems Corporation</italic>, Otawara, Japan) at InCor - HCFMUSP.</p>
      <p>Patients were informed about exam details, and positioned at the MDCT table in dorsal decubitus, dislocated towards the right, keeping their heart at X-Ray central focus. All patients were monitored electrocardiographically for synchronization with image acquisition and heart rate (HR) follow-up during the exam. Patients' arms were positioned above their head, and ECG leads off scan field.</p>
      <p>Patients' heart rate (HR) during the exam was 61.1&#177;6.9 bpm. Patients with heart rate (HR) above 70bpm at the time they reached CT Scan location received IV beta-blocker, metoprolol at the proper dose to reach target HR (60bpm) or to the maximum dose (15mg), since their protocol included associated coronary angiotomography acquisition. Heart rate was always measured during respiratory pause.</p>
      <p>
        <bold>MDCT protocol - image acquisition</bold>
      </p>
      <p>At a first moment the so-called scout images were obtained. Based on the first image, a scanning window would be visually established, covering from tracheal bifurcation (carina) up to the inclusion of cardiac silhouette. This design was used to obtain calcium score.</p>
      <p>Calcium score was then obtained through prospective acquisition, and synchronized to ECG tracing. Images acquired were 3.0 mm thick, and view field was from 200 to 220mm for chest axial images covering all cardiac area and allowing the visualization of coronary arteries and possible calcification on coronary artery topography. Images were acquired at a diastolic moment that was defined following patient's heart rate. Calcium score required an average 15s inspiratory pause as per validated Protocol<sup>9</sup> to be obtained Calcium score parameters were: 0.75s tube rotation speed, 4.0 x 3.0 mm detector collimation, 120 kV tube voltage, and 300 mA tube flow.</p>
      <p>
        <bold>Invasive coronary angiography acquisition</bold>
      </p>
      <p>Coronary angiographies were performed using renowned techniques that have been standardized at InCor, HC-FMUSP<sup>10</sup> hemodynamics service techniques and with clinical indication that is independent from the research Protocol.</p>
      <p>
        <bold>Follow-up of cardiovascular events</bold>
      </p>
      <p>Follow-up data were obtained from at least one of the three sources:</p>
      <p>1) routine visit at specialized outpatient unit;</p>
      <p>2) telephone call to patient or relative to check on patient's health status;</p>
      <p>3) review of patient's medical record.</p>
      <p>The Protocol considered the following as cardiovascular events: cardiac death (consensually declared by 2 cardiologists after reviewing available data); acute myocardial infarction (AMI) (threefold enzyme increase as compared to normal values, associated to acute chest pain and/or ECG changes that are compatible with myocardial ischemia), cerebrovascular accident (clinical or imaging diagnosis), severe peripheral vascular disease or gangrene (severe ischemia of limbs leading to associated surgical procedure), Unstable angina (typical chest pain, ECG changes that are compatible with myocardial ischemia in patients presenting the likelihood of moderate CAD at least), congestive heart failure (clinical diagnosis and echocardiogram showing reduction of LV ejection fraction), and acute lung edema (clinical diagnosis and chest X-Ray, with evidence of interstitial pulmonary edema).</p>
      <p>
        <bold>Data analysis</bold>
      </p>
      <p>
        <bold>Calcium score analysis</bold>
      </p>
      <p>Total calcium score - as per method described by Agatston et al<sup>9</sup> - was obtained for each patient (<xref ref-type="fig" rid="f1-body3">Figure 1</xref>) through workstation <italic>Vitrea</italic>&#153;2, version 3.5 <italic>- Vital Images Inc</italic>, Plymouth, MN, EUA. For calcium score images analysis, two measures were used: Agatston<sup>9</sup> Score and calcium volume. Agatston Score has been most commonly found in the literature. It keeps an association with coronary disease and even with obstructive CAD if at very high levels (percentile above 75% or at 90%).</p>
      <fig id="f1-body3">
        <graphic xlink:href="1678-4170-abc-94-02-0252-00018-gf01-en.jpg"/></fig>
      <p>
        <bold>Quantitative coronary angiography (QCA)</bold>
      </p>
      <p>An observer experienced in QCA technique and who did not participate in the MDCT analysis - also blind and independent - analyzed all ICA by using <italic>QCA</italic> (Coronary Analysis Angiographic System - CASS II, <italic>Pie Medical Imaging BV</italic> &#153;, Maastricht, The Netherlands)<sup>11-14</sup>.</p>
      <p>Stenosis diameter - visually considered at least as intermediate (<underline>&gt;</underline> 50%) - was objectively, percentually assigned in relation to "reference diameter" (the diameter of the same vessel that was disease free, immediately proximal to stenosis). The diameter is determined orthogonally, with average determining final stenosis severity.</p>
      <p>All injuries with reference diameter <underline>&gt;</underline> 1.5 mm were included in the comparative analysis for the present study. Should the same segment in main artery or first order branch present more than one significant stenosis, only the most severe stenosis would be compared to its correspondent through MDTC<sup>10,15,16</sup>.</p>
      <p>
        <bold>Statistical analysis</bold>
      </p>
      <p>Descriptive variables were expressed as means, SD and medians, whenever appropriate. Having presented an asymmetric distribution curve, coronary artery calcification levels were expressed through medians, percentiles, and end points.</p>
      <p>With the purpose of establishing MDCT diagnosis accuracy, the authors resorted to a classic 2x2 table.</p>
      <p>Fisher exact test was used to calculate MDCT diagnosis accuracy as compared to <italic>QCA</italic> in regard to the identification of <underline>&gt;</underline> 50% and <underline>&gt;</underline> 70%.coronary stenosis. In order to compare the different coronary calcium scores obtained through MDCT at corresponding sites, Mann-Whitney test was used.</p>
      <p>Kaplan-Meier curves were also used for time events analysis in the different subgroups. All analyses were performed using Stata&#153;/SE 8 (StataCorp LP, College Station, TX).</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>Agatston mean score for the sample of CRF patients was 580.6 &#177; 1,102.2. Minimum and maximum values ranged from 0 to 7,994. Out of the 97 patients analyzed for calcium score, only 14 patients failed to have detectable coronary calcification, which means to say, zero calcium score. <xref ref-type="table" rid="t2-body3">Table 2</xref> also shows score values and total volume for the whole coronary tree as well as specific coronary territories, with means, SD, medians, and minimum and maximum values for each category. <xref ref-type="table" rid="t3-body3">Table 3</xref> shows percentiles for age and gender. Mean percentile values for age, gender, and ethnicity based on the MESA (Multiethnic Study of Atherosclerosis) Study are referred to as MESA in <xref ref-type="table" rid="t3-body3">Table 3</xref>.</p>
      <table-wrap id="t2-body3">
        <graphic xlink:href="1678-4170-abc-94-02-0252-00018-gt02-en.jpg"/></table-wrap>
      <table-wrap id="t3-body3">
        <graphic xlink:href="1678-4170-abc-94-02-0252-00018-gt03-en.jpg"/></table-wrap>
      <p>CCS distribution is significantly asymmetric. Therefore, total Agatston score median as well as its percentile distribution have been reported (<xref ref-type="table" rid="t3-body3">Table 3</xref>).</p>
      <p>As for patients ethnicity, no significant CCS difference was reported in the different ethnic groups.</p>
      <p>
        <bold>Calcium score <italic>versus</italic> coronary stenosis</bold>
      </p>
      <p>Calcification level between patients with or without significant obstructive coronariopathy (stenosis <underline>&gt;</underline>70%) was compared. It was demonstrated through Wilcoxon test (<xref ref-type="table" rid="t2-body3">Table 2</xref>) that Agatston score is significantly higher in the group reporting significant CAD on catheterization. Time elapsed between MDCT ICA was in average 99.03 days, SD 87.65 days, and median 79 days. Minimum interval was 2 days, and maximum interval was 380 days. Only 2 cases exceeded 1 year, and 16 cases had an interval over 6 months.</p>
      <p>Patients with <underline>&gt;</underline> 50% and <underline>&gt;</underline> 70% coronary stenosis on ICA were assessed for the different CCS extracts. A significant, progressive, linear increase in the number of CAD patients and coronary calcification level (<xref ref-type="fig" rid="f2-body3">Figure 2</xref>) could be observed. A total of 55/97 (57%) patients presented stenosis from <underline>&gt;</underline>50% ICA; and 25/97 (26%) from <underline>&gt;</underline>70%.</p>
      <fig id="f2-body3">
        <graphic xlink:href="1678-4170-abc-94-02-0252-00018-gf02-en.jpg"/></fig>
      <p>When coronary calcification was evaluated against ICA it could be observed that for <underline>&gt;</underline> 50% and <underline>&gt;</underline> 70% stenosis Agatston's score of 400 threshold was statistically associated to a higher number of significant stenosis (p &lt; 0.001, by Chi-square, <xref ref-type="fig" rid="f2-body3">Figure 2</xref>).</p>
      <p>Regional analysis of calcium score also showed the same differences as observed for global score, except on left main coronary artery. Therefore, regional scores were significantly higher in segments with <underline>&gt;</underline> 50% and 70% when compared to segments with no stenosis.</p>
      <p>Calcium score accuracy in coronary stenosis diagnosis was also evaluated using the MESA Study (75<sup>th</sup> percentile). Data can be found in <xref ref-type="table" rid="en_18t04-body3">Table 4</xref>.</p>
      <p content-type="asset">
        <table-wrap id="en_18t04-body3">
          <graphic xlink:href="1678-4170-abc-94-02-0252-00018-gt04-en.jpg"/></table-wrap>
      </p>
      <p>From the 14 zero calcium score patients, 4 (28%) presented <underline>&gt;</underline>50% stenosis on ICA and only 2 (14%) <underline>&gt;</underline> 70% stenosis. While using binary calcium score - zero or higher than zero - as a predictor for coronary stenosis, our sample showed a negative predictive value: 71% for <underline>&gt;</underline>50% stenosis and 86% for <underline>&gt;</underline>70% stenosis.</p>
      <p>
        <bold>Calcium score as a predictor for coronary stenosis</bold>
      </p>
      <p>The authors also investigated - by logistic regression and ROC curves - whether calcium score is successful in predicting coronary stenosis on ICA.</p>
      <p>They investigated the accuracy of calcium score through ROC curve analysis both for the 50% stenosis threshold (AUC = 0.75) and the 70% threshold (AUC = 0.70), as defined on ICA (<xref ref-type="fig" rid="en_18f03-body3">Figure 3 - A</xref> for 50% and <xref ref-type="fig" rid="en_18f03-body3">B</xref> for 70% threshold).</p>
      <p content-type="asset">
        <fig id="en_18f03-body3">
          <graphic xlink:href="1678-4170-abc-94-02-0252-00018-gf03-en.jpg"/></fig>
      </p>
      <p>Based on logistic regression and on ROC curves, the authors could say that calcium score does predict <underline>&gt;</underline>50% coronary stenosis on ICA, at 186.53 as the best threshold, 66% accuracy, 65% sensitivity, 66% specificity, 72% positive predictive value and 60% negative predictive value (p=0.01).</p>
      <p>Likewise, calcium score does predict <underline>&gt;</underline>70% coronary stenosis on ICA, at 1330.72 as the best threshold, 65% accuracy, 64% sensitivity, 65% specificity, 39% positive predictive value and 84% negative predictive value (p=0.01).</p>
      <p>Those thresholds were also the ones to present the best possible negative predictive values, therefore answering the question as to the calcium score level that can be predictive of the absence of significant stenosis.</p>
      <p>
        <bold>Calcium score <italic>versus</italic> cardiovascular events</bold>
      </p>
      <p>Average follow-up time for the evaluation of events in our population was 29.1&#177;11.0 months, with median at 31 months, and minimum follow-up time of 3 months, and maximum of 43 months. Events observed and their absolute frequency were: acute myocardial infarction (AMI) (8), cerebrovascular accident (5), severe peripheral vascular disease or gangrene (4), unstable angina (2), sudden death (2), congestive heart failure (1), and acute lung edema (1). The total number of events was 23. Out of the 97 patients, 23 presented events (23.7% in the sample). No events were reported by 71 patients; and 3 were lost to follow-up.</p>
      <p>As for CCS as a predictor in this population, the authors observed that MESA study percentile for the same population did not prove to be a significant predictor, either for percentile 75th and 90% threshold.</p>
      <p>Also while analyzing events, the authors investigated calcium score as predictive of events at different cut-off thresholds: 0 (presence or absence), 10, 100 and 400. The 400 calcium score threshold showed Kaplan-Meier curves with rate of significantly different events (<xref ref-type="fig" rid="f4-body3">Figure 4</xref>).</p>
      <fig id="f4-body3">
        <graphic xlink:href="1678-4170-abc-94-02-0252-00018-gf04-en.jpg"/></fig>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>The present research work was the first to show that MDCT does provide prognostic information about CRF patients who are candidates for renal transplant.</p>
      <p>CCS proved to have a correlation with the presence of stenosis, as well as good diagnostic performance in regard to ICA in detecting stenosis. It also showed prognostic performance of Agatston score of 400 as cut-off point in our population.</p>
      <p>Average scores showed to be quite high. Scores above 300 or 400 have been reported in the literature for non-CRF patients as associated to a high probability of obstructive CAD and high risk of cardiovascular events<sup>17,18</sup>.</p>
      <p>CRF patients on dialysis have reported a 2.5 fold magnitude for coronary calcification<sup>19-22</sup>. However, such high level has mostly been related to traditional CAD risk factors in this population rather than factors associated to renal function of dialysis<sup>23</sup>. Vascular calcification is described as related to dialysis. It is called uremic arteriopathy, and is characterized by diffuse calcification of artery middle layer, and thrombosis that may result in ulcer and skin necrosis. It is not yet clear to what extent that mechanism may influence coronary artery calcification in this group of patients<sup>24</sup>.</p>
      <p>Although only a partial correlation could be observed between calcification and coronary obstruction in the general population<sup>18</sup>, good diagnostic correlation and accuracy could be seen between calcium score and coronary stenosis through MDCT and ICA in the CRD group of patients. Percentile 75<sup>th</sup> in the MESA study showed 82% sensitivity and 84% detection for CAD with <underline>&gt;</underline> 50% and 70% obstructive stenosis respectively. The outcome seems to be highly encouraging for the use of such simple technique, with low radiation level and no need for contrast agents. Those sensitivity levels are not typically reached, not even by pharmacological stress tests such as scintigraphy and echocardiogram. In a study conducted by our group using a cardiac MRI dipyridamole stress test and scintigraphy, 84% and 66% sensitivity levels were respectively obtained for this population of patients<sup>25</sup>. However, both MRI and other stress tests are complex, time-consuming, and quite expensive tests, posing higher risk to patients when compared to calcium score.</p>
      <p>The use of absolute calcium score provided sensitivity levels lower than those reached by 75th percentile. Therefore, the authors have concluded that MESA study 75th percentile was the most accurate to detect CAD when compared to absolute calcium score. Absolute calcium score best accuracy to detect stenosis was <underline>&gt;</underline>50%, while ICA was 186. Those threshold values have reported the best possible negative predictive value in the sample. Therefore, our data indicate that &lt;186 calcium score - or under 75th percentile - may rule out significant coronary stenosis at a level close to 90% in this group of patients. So, calcium score seems to be even more significant in the CRF group of patients. That correlation showed to be true both for global and regional Agatston score. It should also be pointed out that coronary angiotomography may be of limited effectiveness for patients reporting high calcification level for luminal reduction evaluation, although special techniques and experienced observers may turn such assessment clinically useful<sup>26</sup>.</p>
      <p>Data in the literature have shown calcium score as a more effective predictor of cardiovascular events when compared to coronary stenosis for patients in the general population<sup>17</sup>. MESA study has recently confirmed such data in the different ethnic groups<sup>27</sup>, thus emphasizing the prognostic role played by calcium score. The present study has shown that the correlation between calcium and events among CRF patients was significant for Agatston score of 400, thus suggesting that it may be used as predictive prognostic threshold. Therefore, out data suggest that in the CRF group of patients calcium score does hold predictive value not only for events but also for the detection of coronary stenosis, differently from what was observed in the general population. In that respect, the 7 patients with previous myocardial infarction were a limiting component faced by the present study, since that may have increased the diagnostic power of the test in this specific population. However, when those patients were excluded in a sensitivity analysis, no significant change was observed in the diagnostic performance of calcium score in our group.</p>
      <p>On the other hand, our study has resorted to recently described, advanced methodology for coronary tree segmentation and for statistical analysis<sup>28</sup>, which stands for some evolution in the scientific method in this field. Our groups has used it in a highly impacting multicenter study<sup>29</sup>.</p>
      <p>Some relevant implications from the results in the present study, associated to data collected by the authors as well as available in the literature, may be found to be of clinical use.</p>
      <p>Considering the high number of ICA reporting absence of CAD or non-obstructive CAD (approximately 40%)<sup>30</sup>, associated to characteristics of the excellent safety profile shown by calcium score, as well as the low cost and good sensitivity level shown by the present study results for CRF patients, it seems it is a good, cost-effective tool for the detection of CAD. Cost-effectiveness was not an objective in the present study. That should be done in future projects that focus this kind of analysis in a direct fashion.</p>
      <p>
        <bold>Conclusion</bold>
      </p>
      <p>The authors state that calcium score through CT Scan has shown to be a good diagnostic predictor of coronary stenosis (75 percentil and 186 absolute value), and a good prognostic predictor of cardiovascular events (400 absolute value) among renal failure patients.</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>This study was funded by FAPESP and Zerbini Foundation.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the doctoral thesis of Miguel Abra&#227;o Ros&#225;rio, from <italic>Instituto do Cora&#231;&#227;o (Incor) do Hospital das Cl&#237;nicas da Faculdade de Medicina da Universidade de S&#227;o Paulo</italic>.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
</article>
